<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2023.1090081</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Thyroid hormone action controls multiple components of cell junctions at the ventricular zone in the newborn rat brain</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>O&#x2019;Shaughnessy</surname>
<given-names>Katherine L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/601127"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McMichael</surname>
<given-names>Benjamin D.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sasser</surname>
<given-names>Aubrey L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bell</surname>
<given-names>Kiersten S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1933693"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Riutta</surname>
<given-names>Cal</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ford</surname>
<given-names>Jermaine L.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2141157"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stoker</surname>
<given-names>Tammy E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grindstaff</surname>
<given-names>Rachel D.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pandiri</surname>
<given-names>Arun R.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1401423"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gilbert</surname>
<given-names>Mary E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/46394"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>United States Environmental Protection Agency, Public Health Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Research Triangle Park</institution>, <addr-line>NC</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Oak Ridge Institute for Science Education</institution>, <addr-line>Oak Ridge, TN</addr-line>, <country>United States</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Chemical Characterization and Exposure Division, Center for Computational Toxicology and Exposure, United States Environmental Protection Agency, Research Triangle Park</institution>, <addr-line>NC</addr-line>, <country>United States</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Comparative and Molecular Pathogenesis Branch, Division of Translational Toxicology, National Institute of Environmental Health Sciences</institution>, <addr-line>Research Triangle Park, NC</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Laurent M. Sachs, Mus&#xe9;um National d&#x2019;Histoire Naturelle, France</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Fr&#xe9;d&#xe9;ric Flamant, Universit&#xe9; de Lyon, France; Thomas Bastian, University of Minnesota Twin Cities, United States; Robert Opitz, Charity University Medicine Berlin, Germany</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Katherine L. O&#x2019;Shaughnessy, <email xlink:href="mailto:oshaughnessy.katie@epa.gov">oshaughnessy.katie@epa.gov</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Thyroid Endocrinology, a section of the journal Frontiers in Endocrinology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>02</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1090081</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>01</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 O&#x2019;Shaughnessy, McMichael, Sasser, Bell, Riutta, Ford, Stoker, Grindstaff, Pandiri and Gilbert</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>O&#x2019;Shaughnessy, McMichael, Sasser, Bell, Riutta, Ford, Stoker, Grindstaff, Pandiri and Gilbert</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Thyroid hormone (TH) action controls brain development in a spatiotemporal manner. Previously, we demonstrated that perinatal hypothyroidism led to formation of a periventricular heterotopia in developing rats. This heterotopia occurs in the posterior telencephalon, and its formation was preceded by loss of radial glia cell polarity. As radial glia mediate cell migration and originate in a progenitor cell niche called the ventricular zone (VZ), we hypothesized that TH action may control cell signaling in this region. Here we addressed this hypothesis by employing laser capture microdissection and RNA-Seq to evaluate the VZ during a known period of TH sensitivity. Pregnant rats were exposed to a low dose of propylthiouracil (PTU, 0.0003%) through the drinking water during pregnancy and lactation. Dam and pup THs were quantified postnatally and RNA-Seq of the VZ performed in neonates. The PTU exposure resulted in a modest increase in maternal thyroid stimulating hormone and reduced thyroxine (T4). Exposed neonates exhibited hypothyroidism and T4 and triiodothyronine (T3) were also reduced in the telencephalon. RNA-Seq identified 358 differentially expressed genes in microdissected VZ cells of hypothyroid neonates as compared to controls (q-values &#x2264;0.05). Pathway analyses showed processes like maintenance of the extracellular matrix and cytoskeleton, cell adhesion, and cell migration were significantly affected by hypothyroidism. Immunofluorescence also demonstrated that collagen IV, F-actin, radial glia, and adhesion proteins were reduced in the VZ. Immunohistochemistry of integrin &#x3b1;v&#x3b2;3 and isoforms of both thyroid receptors (TR&#x3b1;/TR&#x3b2;) showed highly overlapping expression patterns, including enrichment in the VZ. Taken together, our results show that TH action targets multiple components of cell junctions in the VZ, and this may be mediated by both genomic and nongenomic mechanisms. Surprisingly, this work also suggests that the blood-brain and blood-cerebrospinal fluid barriers may also be affected in hypothyroid newborns.</p>
</abstract>
<kwd-group>
<kwd>thyroid hormone action</kwd>
<kwd>hypothyroidism</kwd>
<kwd>brain development</kwd>
<kwd>ventricular zone</kwd>
<kwd>cell migration</kwd>
<kwd>radial glia</kwd>
<kwd>cell adhesion</kwd>
<kwd>cell junctions</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="87"/>
<page-count count="16"/>
<word-count count="8763"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Thyroid hormone (TH) action controls multiple developmental pathways in the brain (reviewed in <xref ref-type="bibr" rid="B1">1</xref>). These thyroid-dependent processes all exhibit striking spatiotemporal activity, with subcompartments of the brain exhibiting differing sensitivities to THs, which also varies with developmental time (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>).</p>
<p>Highlighting these spatiotemporal dynamics, we previously reported that a transient maternal exposure to the propylthiouracil (PTU) resulted in the formation of a periventricular heterotopia in the developing rat brain (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). This malformation is not only inducible by anti-thyroid pharmaceuticals, but also by environmental thyroid disrupting chemicals in multiple strains of rats (<xref ref-type="bibr" rid="B3">3</xref>&#x2013;<xref ref-type="bibr" rid="B9">9</xref>). The heterotopia is predominantly comprised of ectopic neurons and can be detected in 100% of pups following a 5-day perinatal exposure (gestational day 19 &#x2013; postnatal day 2, GD19 &#x2013; PN2) (<xref ref-type="bibr" rid="B4">4</xref>). In addition to a clear temporal susceptibility, we also identified a spatial sensitivity to TH action. The heterotopia reproducibly occurs in the posterior telencephalon, directly medial to the lateral ventricular epithelium as this region extends into the corpus callosum (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B5">5</xref>&#x2013;<xref ref-type="bibr" rid="B8">8</xref>). Given these data, we hypothesized that the developing ventricular epithelium is acutely sensitive to reduced TH action during the perinatal period in the rat. We postulated that this may be due in part to its anatomical location. The most luminal cells come in direct contact the cerebrospinal fluid (CSF), one source of brain THs (<xref ref-type="bibr" rid="B10">10</xref>). The ventricular epithelium also possesses an enriched vascular network, and as THs are also actively transported across the blood-brain barrier (BBB), the microvasculature represents a second source of brain T4/T3 (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B11">11</xref>). Thus, the cells of the ventricular epithelium reside at the intersection of TH transport.</p>
<p>In addition to being a potential target of TH action, the neonatal ventricular epithelium is also one of two stem cell niches that supports neurogenesis. The most apical proliferative population is the ventricular zone (VZ), and houses multipotent stem cells, namely radial glia (<xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>). Importantly, while radial glia are progenitors, they also act as migratory scaffolding to mediate the travel of neuroblasts into regions like the cortex (<xref ref-type="bibr" rid="B14">14</xref>). The next most basal cell layer is called the subventricular zone (SVZ), which also possesses undifferentiated cells including intermediate progenitors (<xref ref-type="bibr" rid="B14">14</xref>&#x2013;<xref ref-type="bibr" rid="B16">16</xref>). Unlike the SVZ, which supports neurogenesis throughout life, the VZ is only present during embryonic and early postnatal development in rodents (<xref ref-type="bibr" rid="B13">13</xref>). The VZ appears as the pseudostratified ventricular epithelium due to the cell bodies of numerous radial glia (<xref ref-type="bibr" rid="B13">13</xref>). By approximately 2-weeks of age, the pseudostratified epithelium remodels to simple columnar as radial glia cells differentiate, leaving the SVZ with only limited proliferative capacity (<xref ref-type="bibr" rid="B13">13</xref>). These dynamics between VZ/SVZ transition during the postnatal period, in addition to the VZ&#x2019;s anatomical location, may also contribute to TH susceptibility.</p>
<p>Here we investigated the hypothesis that the posterior VZ is a target of TH action during the neonatal period in rats. We exposed pregnant animals to a low dose of propylthiouracil (PTU) beginning in early pregnancy. Using laser capture microdissection (LCM), we isolated cells of the posterior VZ in pups during a known period of hormone sensitivity (PN2) (<xref ref-type="bibr" rid="B4">4</xref>). We then employed RNA-Sequencing (RNA-Seq) and pathway analyses to investigate the molecular pathways disturbed in affected neonates. Next, we performed immunohistochemistry to garner further support of our RNA-Seq findings, which includes mediators of TH action.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Animal husbandry and exposure</title>
<p>All experiments were conducted with prior approval from the United States Environmental Protection Agency&#x2019;s (US EPA&#x2019;s) Institutional Animal Care and Usage Committee and were carried out in an Association for Assessment and Accreditation of Laboratory Animal Care approved facility. N=16 timed pregnant Long Evans rats were purchased from Charles River (Morrisville, NC) and delivered on gestational day (GD) 2; sperm positive was considered GD0 and pup birth postnatal day 0 (PN0). Dams were single housed in polycarbonate cages, maintained a 12:12 light cycle and offered chow (Purina 5008) and deionized water ad libitum. Animals were weight ranked and then randomly allocated to two treatment groups. N=8 dams were exposed to 3 ppm (0.0003%) 6-propyl-2-thiouracil (PTU, purity &#x2265;98%, Sigma) dissolved in deionized drinking water; N=8 control dams were administered vehicle only (deionized drinking water). The maternal exposure was initiated on GD6 and continued through PN14. This PTU exposure was not expected to induce overt toxicity in dams, but was sufficient to induce a periventricular heterotopia in their offspring (<xref ref-type="bibr" rid="B3">3</xref>). N=8 controls and N=7 PTU exposed dams gave birth.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Serum thyroid hormone quantification</title>
<p>To evaluate serum total thyroxine (T4), triiodothyronine (T3), and thyroid stimulating hormone (TSH), pups on PN2 and dams on PN14 were euthanized by rapid decapitation and trunk blood collected in serum separator tubes with clot activating gel (BD Vacutainer). Serum hormones were quantified from N=8 vehicle control and N=7 PTU exposed dams and litters. Pup blood was pooled from two littermates, taking one male and one female from each litter when possible. Previous work has shown that PTU exposure similarly reduces serum T4 and T3 in both sexes of rats (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>). Blood samples were allowed to clot on ice for at least 30 minutes before centrifugation at 1300 x g (4&#xb0; C). Serum was then aliquoted in sterile, nonstick tubes and stored at -80&#xb0;C until analysis. Pups were analyzed on PN2 due to our previous work demonstrating that TH dysfunction at this stage is associated with periventricular heterotopia development (<xref ref-type="bibr" rid="B4">4</xref>). The dams were euthanized at the conclusion of this animal exposure on PN14; other data collected from this animal cohort will be published elsewhere. For further information on dam serum TH profiles over the perinatal period following a 3 ppm PTU exposure, see (<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>Serum T4 and T3 were analyzed by liquid chromatography with tandem mass spectrometry using an AB Sciex (Framingham, Massachusetts) Exion AC UHPLC-Qtrap 6500+ Linear Ion Trap LC/MS/MS system as previously described (<xref ref-type="bibr" rid="B19">19</xref>). The lower limit of quantitation (LLOQ) for each analyte was set to the concentration of the lowest calibration standard that gave an acceptable ion ratio, and acceptable recovery of &#xb1;30% of the spike amount; the lower limit of quantification (LLOQ) for both T4/T3 were 0.1&#x2009;ng/ml (100 pg/ml). Each sample batch consisted of a method blank, a laboratory control sample (blank spike), and a continuing calibration verification sample prepared in the solvent. Serum TSH was analyzed on using a Milliplex Rat Thyroid Hormone Magnetic Bead Panel (Millipore Sigma, RTHYMAG-30K-01) according to the manufacturer&#x2019;s protocol. The curve fit R<sup>2</sup> was &gt;0.99 and the sum of residuals was -0.004. Unpaired, two-tailed Welch&#x2019;s t-tests with an &#x3b1;=0.05 were performed for each measured analyte using GraphPad Prism 9.1.2 (GraphPad Software, San Diego, CA).</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Brain hormone quantification</title>
<p>Following rapid decapitation, the brain from one female pup per litter was extracted from the skull and the telencephalon (forebrain) isolated in sterile 0.01 M phosphate buffered saline (PBS). Tissue was blotted to remove excess buffer, weighed, placed in sterile tubes, and frozen in liquid nitrogen. All samples were stored at -80&#xb0;C until analysis. THs were isolated by solid phase extraction and analyzed by LC/MS/MS as previously described (<xref ref-type="bibr" rid="B19">19</xref>) for N=5 control and N=5 PTU exposed samples. The LLOQ for total T4 and reverse T3 (rT3) were 0.01&#x2009;ng/g and total T3 0.05 ng/g. Unpaired, two-tailed Welch&#x2019;s t-tests with an &#x3b1;=0.05 were performed for each TH measured using GraphPad Prism 9.1.2 (GraphPad Software, San Diego, CA). Previous work has shown no differences in heterotopia incidence or severity between the sexes, suggesting that sex not a significant variable in determination of this phenotype (<xref ref-type="bibr" rid="B3">3</xref>). Hence, only female brain hormones were assessed.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Laser capture microdissection</title>
<p>One male pup was selected from each of N=7 control and N=6 PTU exposed litters on PN2 for laser capture microdissection (LCM) and sequencing. Pups were administered an overdose of Euthasol<sup>&#xae;</sup> and transcardiac perfusion performed with 30% sucrose in sterile 0.01 M PBS pH 7.4. Following sucrose perfusion, the brain was immediately dissected from the skull, embedded in Tissue Freezing Medium&#x2122; (Fisher Scientific, 15-183-13), and frozen on a slurry of dry ice and isopentane. The brains were cryosectioned coronally at 10 &#xb5;m thickness and collected directly onto MicroDissect polyethylene terephthalate membrane single frame slides (ASEE, FS-LMD-M-50r); slides were placed on dry ice immediately after section pickup and stored -80&#xb0;C. Immediately before microdissection slides were stained with 2% cresyl violet in 75% ethanol, dehydrated, and cleared. Laser capture of the posterior ventricular epithelium was then performed using a MMI CellCut LCM System (Molecular Machines and Industries). The epithelium as identified by its pseudostratified appearance, consistent with reports that this morphology represents the VZ (<xref ref-type="bibr" rid="B13">13</xref>). Isolated cells were then collected using 0.5&#xa0;ml MicroDissect stick-cap tubes (ASEE, ST-LMD-M-500). The ventricular epithelium from both hemispheres of ~20 sections was collected from each animal.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>RNA isolation</title>
<p>RNA was isolated using Qiagen&#x2019;s RNeasy<sup>&#xae;</sup> Micro kit (Qiagen, 74004). Immediately after cells from each slide were collected as described, 10 &#xb5;l of RLT lysis buffer was added directly on to the cap for 5 minutes. RNA was isolated from lysed cells according to the manufacturer&#x2019;s protocol, including on-column DNA digestion. RNA concentrations were determined using Qubit (RNA HS, Q32852) and quality using Agilent Bioanalyzer (Nano, 5067-1511). The average RNA concentration across biological replicates was 15 ng/&#xb5;l and RNA Integrity Number was (RIN) 5.3. While this indicates some RNA degradation, slide control cells (microdissected CA1/CA3 of the hippocampus) revealed consistently intact RNA with RIN &#x2265;8 across all biological replicates (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure 1</bold>
</xref>). Therefore, we attributed the lower RINs of our microdissected VZ to the long, narrow shape of this region, which likely resulted in an increased amount of burned cellular debris relative to intact cells following microdissection.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Library preparation and RNA-Sequencing (RNA-Seq)</title>
<p>Total RNA-Sequencing libraries were prepared using the SMARTer<sup>&#xae;</sup> Stranded Total RNA-Seq Kit v3 - Pico Input Mammalian kit (Takara, 634485) according to the manufacturer&#x2019;s protocol. This included sample barcoding and rRNA depletion. Library quantities were evaluated using Qubit (dsDNA, Q32851) and library size and quality evaluated using Agilent Bioanalyzer (DNA HS, 5067-4626). Libraries were pooled and sequenced on two lanes of Illumina HiSeq 4000 and paired end sequenced to an average depth of 58 million reads/sample.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Identifying differentially expressed genes (DEGs)</title>
<p>Samples were demultiplexed and trimmed using Trimmomatic (<xref ref-type="bibr" rid="B20">20</xref>). Downstream processing of RNA-Seq data was performed in Partek Flow Bioinformatics Software (Chesterfield, MO). Samples were aligned to the <italic>Rattus norvegicus</italic> reference genome (mRatBN7.2/rn7) using STAR 2.7.8a. Counts were quantified using the Partek Expectation/Maximization (E/M) model and the rat RefSeq annotation (GCF_015227675.2) and normalized using median ratio. Differential expression was identified by comparing N=6 PTU exposed samples to N=7 controls using DESeq2 (<xref ref-type="bibr" rid="B21">21</xref>), and multiple testing corrected using the Benjamini&#x2013;Hochberg step-up procedure to control the False Discovery Rate (FDR). DEGs were identified by an FDR (q-value) &#x2264;0.05. A volcano plot was generated using the ggplot2 R package (<xref ref-type="bibr" rid="B22">22</xref>), and a heatmap of normalized count values using the Pheatmap (<xref ref-type="bibr" rid="B23">23</xref>) and Viridis R packages (<xref ref-type="bibr" rid="B24">24</xref>).</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Gene ontology and pathway analyses</title>
<p>For preliminary investigation of the RNA-Seq data, all differentially expressed genes (DEGs) with a q-value &#x2264;0.05 were analyzed using Gene Ontology (GO) in STRING (<xref ref-type="bibr" rid="B25">25</xref>). Results within the sub-ontologies of Cellular Components and Biological Function are reported here, with an adjusted p-value (q) &#x2264;0.05 considered significant. Next, significant DEGs (q &#x2264; 0.05) were analyzed in Ingenuity Pathway Analysis (IPA) (Qiagen, Hilden, Germany) and used to generate predicted canonical and disease and function pathway analyses between control and PTU exposure.</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Immunohistochemistry and imaging</title>
<p>A subset of PN2 pups of both sexes were euthanized for immunohistochemistry. Pups were administered an overdose of Euthasol<sup>&#xae;</sup> and perfused with sterile 0.01 M PBS pH 7.4, and then 4% paraformaldehyde. Brains were isolated and cryoprotected in 30% sucrose in PBS before embedding in Tissue Freezing Medium&#x2122; (Fisher Scientific, 15-183-13). Blocks were frozen on a slurry of dry ice and isopentane. The brains were cryosectioned coronally at 35 &#xb5;m and collected in PBS for free-floating immunohistochemistry (IHC). All primary and secondary antibody combinations can be found in <xref ref-type="supplementary-material" rid="ST1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>. For fluorescent IHC, nonspecific binding was blocked in a mixture of 10% horse and goat serum in PBS with 0.1% triton-X for 2 hours. Primary antibodies were then diluted in block buffer and incubated overnight at 4&#xb0;C. The sections were then washed in PBS and incubated with appropriate Alexa Fluor antibodies and counterstained with DAPI. For visualization of filamentous actin (F-actin), sections were incubated in 0.5% triton for 15 minutes before incubation in Alexa Fluor 647 phalloidin according to manufacturer&#x2019;s protocol (Abcam, ab176759). Fluorescent sections were then mounted on SuperFrost Plus (Fisher Scientific, 12-550-15) slides and coverslipped using ProLong Diamond (Thermo Fisher Scientific, P36965). Imaging was performed using a Nikon A1 laser scanning confocal microscope fitted with an Eclipse Ti inverted microscope base and a T-P2 Nikon polarizer slider. Control sections were imaged first and PTU exposed animals analyzed using the same parameters (see laser line information in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>). For calorimetric detection background staining was reduced by incubating in 0.3% hydrogen peroxide diluted in methanol for 30 minutes. Nonspecific binding was reduced in block as stated above, and the signal amplified by avidin-biotin complex (ABC kit, Vector PK-4001 and PK-4002); the color reaction was developed with 3,3&#x2032;-Diaminobenzidine (Sigma, D8001). Slides were then mounted, dehydrated, cleared, and cover slipped before imaging using an Aperio slide scanner (Leica). For all immunohistochemistry experiments at least N=3 control and N=3 PTU exposed pups were analyzed, and all images are representative of repeated findings.</p>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>Figure preparation</title>
<p>Microscopy images were prepared in Adobe Photoshop and figures assembled in Adobe Illustrator, with the same settings applied across control and PTU exposed images.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>PTU exposure perturbed the maternal thyroid axis</title>
<p>Following the drinking water exposure beginning on GD6, PTU significantly reduced dam T4 by 53% as compared to vehicle controls on PN14 (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>, p&lt;0.0001). In contrast, there was no significant change in serum T3 (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>, p=0.33). Serum TSH was increased by 72% (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>, p=0.01). Together, the T4/T3/TSH results shows that PTU exposed dams exhibited thyroid axis perturbation.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Serum thyroid hormones in dams and pups. <bold>(A)</bold> Dam serum T4 is reduced in dams on PN14, whereas <bold>(B)</bold> total T3 was not significantly different. <bold>(C)</bold> TSH was increased by 72% in PTU exposed dams on PN14. <bold>(D)</bold> Pup serum T4 and <bold>(E)</bold> T3 were reduced in pups on PN2. <bold>(F)</bold> TSH was increased in PN2 neonates. In all presented data, N=8 control and N=7 PTU exposed dams or litters were assayed. For all pup data, each biological replicate represents serum pooled from multiple littermates of mixed sex. The data were then analyzed by t-test and each graph shows the value of each biological replicate and the SEM; ****p &#x2264; 0.0001, *p &#x2264; 0.05, ns, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1090081-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Neonatal pups exhibited hypothyroidism and decreased brain T4/T3</title>
<p>On PN2, a known day of hormone susceptibility (<xref ref-type="bibr" rid="B4">4</xref>), serum T4 was reduced in neonates by 80% (p&lt;0.0001) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>) and serum T3 by 39% (p=0.03) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>). Serum TSH was increased by 243% (p&lt;0.0001) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1F</bold>
</xref>). In the telencephalon, T4 was significantly reduced by 80% (p=0.001) and T3 by 38% (p=0.02) (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A, B</bold>
</xref>). Reverse T3 (rT3) was not significantly different following PTU exposure in the neonatal telencephalon (p=0.16) but showed more biological variability than T4/T3 (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). Together, these serum and brain data show that the pups exhibited overt hypothyroidism and decreased brain tissue T4/T3 concentrations.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Telencephalon thyroid hormones in PN2 pups. <bold>(A)</bold> Brain T4 was significantly reduced on PN2, as was <bold>(B)</bold> T3. <bold>(C)</bold> Reverse T3 (rT3) was reduced in PTU exposed animals when comparing group means, but this was not statistically significant. In all presented data, N=8 control and N=7 PTU exposed female pups were assayed (1 pup/litter). The data were then analyzed by t-test and each graph shows the value of each biological replicate and the SEM; **p &#x2264; 0.001, *p &#x2264; 0.05, ns, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1090081-g002.tif"/>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>TH action regulates gene expression at the neonatal ventricular epithelium</title>
<p>To confirm that the posterior ventricular epithelium is the VZ, we performed SRY-Box 2 (SOX2) immunofluorescence. SOX2 is expressed in multipotent neural stem cells, and is enriched in the VZ (<xref ref-type="bibr" rid="B26">26</xref>). Results show that in the posterior telencephalon, strong SOX2 expression was observed in the PN2 ventricular epithelium, which appears pseudostratified when observed by DAPI nuclear staining (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). Following laser capture microdissection of this region and RNA-Seq (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>), 358 DEGs with FDR &#x2264;0.05 were identified in male pups (172 downregulated, 186 upregulated) (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3B&#x2013;D</bold>
</xref>, see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary File 1</bold>
</xref> for full results). Preliminary examination of the dataset revealed a subset of DEGs related to extracellular matrix composition. This included 4 collagen genes with a q&lt;0.05 (<italic>Col8a2</italic>, <italic>Col2a1</italic>, <italic>Col12a1</italic>, <italic>Col4a6</italic>), and 3 approaching statistical significance (q &#x2264; 0.07, <italic>Col9a3</italic>, <italic>Col25a1</italic>, <italic>Col4a5</italic>) (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>, which includes full gene names). All of these collagen transcripts were downregulated except for <italic>Col25a1</italic>. Several other genes encoding extracellular matrix proteins were also significantly downregulated, including a glypican, syndecan, and dystroglyan (<italic>Glp4</italic>, <italic>Sdc2</italic>, <italic>Dag1</italic>). Another subset of DEGs were also related to cytoskeleton formation and/or dynamics. Four genes related to actin or tubulin formation were upregulated (<italic>Actg1</italic>, <italic>Tbcb</italic>, <italic>Tpgs2</italic>, <italic>Tubb2b</italic>, and <italic>Tubb4a</italic>, <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>); three unconventional myosins, which bind F-actin, were all downregulated (<italic>Myo1d</italic>, <italic>Myo1e</italic>, <italic>Myo7a</italic>). A third subgroup of DEGs related to cell adhesion and/or cell junctions were downregulated, including <italic>Cldn1</italic> and <italic>Jam3</italic> (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). Further, genes related to Wnt/Planar cell polarity (<italic>Vangl1</italic>, <italic>Vangl2</italic>), hedgehog signaling (<italic>Gli2</italic>, <italic>Gli3</italic>), and bone morphogenetic protein (BMP) signaling (<italic>Rgma</italic>, <italic>Bmp1</italic>, <italic>Bmper</italic>) were also all downregulated in PTU exposed VZ cells (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). Downregulation of <italic>Spred1</italic> was also detected, a gene we previously implicated in heterotopia development (<xref ref-type="bibr" rid="B4">4</xref>). Surprisingly, only 3 genes were identified as known mediators of TH transport and/or action, including <italic>Slc16a2</italic>, <italic>Tshr</italic>, and <italic>Thrsp</italic>, all of which were downregulated (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>); no deiodinase enzymes (i.e., <italic>Dio2</italic>) or known T4/T3 receptors (i.e., <italic>Thra</italic>, <italic>Thrb</italic>) were differentially expressed in the VZ (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary File 1</bold>
</xref>). Genes known to respond to lowered brain T4/T3, like <italic>Klf9</italic> and <italic>Hr</italic>, were also not amongst the DEGs (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary File 1</bold>
</xref>). We acknowledge that downregulation of <italic>Slc16a2</italic> (MCT8) was a counterintuitive finding. Given that our brain hormone measures show a significant reduction in T3, one would expect upregulation of <italic>Slc16a2</italic> to increase T3 availability at the VZ. While we do not understand why <italic>Slc16a2</italic> is downregulated, it is important to consider if this signal is originating from specific cell types, or is similar across all <italic>Slc16a2</italic> expressing cells. As the apical VZ abuts TH containing CSF and the VZ possesses an enriched BBB, there may be complex mechanisms of regulating TH economy in this region that we cannot discern by bulk RNA-Seq. The lack of transcriptional signal for deiodinases and thyroid receptors is less surprising, as previous gene expression studies of mild/moderate developmental hypothyroidism in the postnatal rat brain have reported similar data (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Genes of interest from RNA-Seq dataset.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="bottom" align="center">Gene Name</th>
<th valign="bottom" align="center">Ensembl ID</th>
<th valign="bottom" align="center">Description</th>
<th valign="bottom" align="center">p-value</th>
<th valign="bottom" align="center">q-value</th>
<th valign="bottom" align="center">Fold change</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="bottom" align="center">
<italic>Gpc4</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000002413</td>
<td valign="bottom" align="center">glypican 4</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.00</td>
<td valign="bottom" align="center">-1.71</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Sdc2</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000004936</td>
<td valign="bottom" align="center">syndecan 2</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.02</td>
<td valign="bottom" align="center">-1.42</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Frem2</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000021670</td>
<td valign="bottom" align="center">FRAS1 related extracellular matrix 2</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.04</td>
<td valign="bottom" align="center">-1.35</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Dag1</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000019400</td>
<td valign="bottom" align="center">dystroglycan 1</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.04</td>
<td valign="bottom" align="center">-1.24</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Col8a2</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000010841</td>
<td valign="bottom" align="center">collagen type VIII alpha 2 chain</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.02</td>
<td valign="bottom" align="center">-1.80</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Col2a1</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000058560</td>
<td valign="bottom" align="center">collagen type II alpha 1 chain</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.02</td>
<td valign="bottom" align="center">-1.93</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Col12a1</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000058470</td>
<td valign="bottom" align="center">collagen type XII alpha 1 chain</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.04</td>
<td valign="bottom" align="center">-1.36</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Col4a6</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000056772</td>
<td valign="bottom" align="center">collagen type IV alpha 6 chain</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.04</td>
<td valign="bottom" align="center">-1.45</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Col9a3</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000009531</td>
<td valign="bottom" align="center">collagen type IX alpha 3 chain</td>
<td valign="bottom" align="center">&lt;0.01</td>
<td valign="bottom" align="center">0.06</td>
<td valign="bottom" align="center">-1.45</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Col25a1</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000050706</td>
<td valign="bottom" align="center">collagen type XXV alpha 1 chain</td>
<td valign="bottom" align="center">&lt;0.01</td>
<td valign="bottom" align="center">0.06</td>
<td valign="bottom" align="center">2.45</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Col4a5</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000018951</td>
<td valign="bottom" align="center">collagen, type IV, alpha 5</td>
<td valign="bottom" align="center">&lt;0.01</td>
<td valign="bottom" align="center">0.07</td>
<td valign="bottom" align="center">-1.37</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Tbcb</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000020781</td>
<td valign="bottom" align="center">tubulin folding cofactor B</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.01</td>
<td valign="bottom" align="center">1.47</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Tpgs2</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000054118</td>
<td valign="bottom" align="center">tubulin polyglutamylase complex subunit 2</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.02</td>
<td valign="bottom" align="center">1.38</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Tubb2b</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000017445</td>
<td valign="bottom" align="center">tubulin, beta 2B class Iib</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.04</td>
<td valign="bottom" align="center">1.22</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Actg1</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000036701</td>
<td valign="bottom" align="center">actin, gamma 1</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.02</td>
<td valign="bottom" align="center">1.21</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Myo1d</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000003276</td>
<td valign="bottom" align="center">myosin ID</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.02</td>
<td valign="bottom" align="center">-1.61</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Myo1e</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000061928</td>
<td valign="bottom" align="center">myosin IE</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.02</td>
<td valign="bottom" align="center">-1.39</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Myo7a</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000013641</td>
<td valign="bottom" align="center">myosin VIIA</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.04</td>
<td valign="bottom" align="center">-1.55</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Ajap1</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000050137</td>
<td valign="bottom" align="center">adherens junctions associated protein 1</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.02</td>
<td valign="bottom" align="center">2.71</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Jam3</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000009149</td>
<td valign="bottom" align="center">junctional adhesion molecule 3</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.02</td>
<td valign="bottom" align="center">-1.29</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Celsr1</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000021285</td>
<td valign="bottom" align="center">Cadherin EGF LAG seven-pass receptor 1</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.02</td>
<td valign="bottom" align="center">-1.37</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Cldn1</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000001926</td>
<td valign="bottom" align="center">claudin 1</td>
<td valign="bottom" align="center">&lt;0.01</td>
<td valign="bottom" align="center">0.05</td>
<td valign="bottom" align="center">-1.81</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Hepacam</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000009219</td>
<td valign="bottom" align="center">hepatic and glial cell adhesion molecule</td>
<td valign="bottom" align="center">&lt;0.01</td>
<td valign="bottom" align="center">0.05</td>
<td valign="bottom" align="center">-1.32</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Vangl1</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000016477</td>
<td valign="bottom" align="center">VANGL planar cell polarity protein 1</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.02</td>
<td valign="bottom" align="center">-1.53</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Vangl2</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000004889</td>
<td valign="bottom" align="center">VANGL planar cell polarity protein 2</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.02</td>
<td valign="bottom" align="center">-1.30</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Gli2</italic>
</td>
<td valign="bottom" align="center">ENSRNOT00000009963</td>
<td valign="bottom" align="center">GLI family zinc finger 2</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.03</td>
<td valign="bottom" align="center">-1.34</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Gli3</italic>
</td>
<td valign="bottom" align="center">ENSRNOT00000019396</td>
<td valign="bottom" align="center">GLI family zinc finger 3</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.05</td>
<td valign="bottom" align="center">-1.35</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Bmp1</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000010890</td>
<td valign="bottom" align="center">bone morphogenetic protein 1</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.04</td>
<td valign="bottom" align="center">-1.35</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Bmper</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000015357</td>
<td valign="bottom" align="center">BMP-binding endothelial regulator</td>
<td valign="bottom" align="center">&lt;0.01</td>
<td valign="bottom" align="center">0.05</td>
<td valign="bottom" align="center">-1.38</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Slc16a2</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000002832</td>
<td valign="bottom" align="center">monocarboxylic acid transporter 8</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.02</td>
<td valign="bottom" align="center">-1.49</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Tshr</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000003972</td>
<td valign="bottom" align="center">thyroid stimulating hormone receptor</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.02</td>
<td valign="bottom" align="center">-1.41</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Thrsp</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000012404</td>
<td valign="bottom" align="center">thyroid hormone responsive</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.04</td>
<td valign="bottom" align="center">-1.42</td>
</tr>
<tr>
<td valign="bottom" align="center">
<italic>Spred1</italic>
</td>
<td valign="bottom" align="center">ENSRNOG00000070996</td>
<td valign="bottom" align="center">sprouty-related EVH1 domain containing 1</td>
<td valign="bottom" align="center">&lt;0.001</td>
<td valign="bottom" align="center">0.02</td>
<td valign="bottom" align="center">-1.25</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Laser capture microdissection and RNA-Seq of the neonatal ventricular zone (VZ). <bold>(A)</bold> Fluorescent immunostaining in control animals demonstrates that the ventricular epithelium (V.E.) of the posterior telencephalon is highly enriched for SOX2, demonstrating that this is the VZ (ventricular zone, progenitor cell niche) on postnatal day 2 (PN2). <bold>(B)</bold> Example of laser capture microdissection of the VZ. <bold>(C)</bold> Volcano plot of resulting RNA-Seq data obtained from microdissected VZ from PN2 male pups, with downregulated (pink) and upregulated (yellow) genes highlighted (q &#x2264; 0.05). <bold>(D)</bold> These differentially expressed genes (DEGs) were then visualized by a heatmap, which shows clear differences between the control (euthyroid) and PTU exposed (hypothyroid) neonates. Each column of the heatmap represents a biological replicate (N=7 control and N, 6 PTU exposed pups).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1090081-g003.tif"/>
</fig>
<p>We next investigated the signaling pathways with overrepresentation amongst the DEGs. Gene Ontology (GO) Cellular Component analysis showed most gene products will localize intracellularly, within the cytoplasm, and at the cell junction (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM2">
<bold>Supplementary File 2</bold>
</xref>). Among the most significant Biological Processes identified include nervous system development (q&lt;0.001), cellular component organization (q=0.002), fiber organization (q=0.002), actin filament organization (q=0.02), lateral sprouting from an epithelium (q=.03), adhesion (q=0.03), and cytoskeletal organization (q=0.03) (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM3">
<bold>Supplementary File 3</bold>
</xref>). A transcriptional signal for circulatory system development was also detected (q=0.03). Ingenuity Pathway Analysis showed similar results as GO Biological Processes. The top Molecular and Cellular Functions include Cellular Assembly and Organization (54 DEGs associated, p-values &lt;0.001) as well as Cell-to-Cell Signaling and Interaction (36 DEGs, p-values &lt;0.001). Between these two categories, there were 68 unique DEGs (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). Highly significant processes within this curated data include cell-cell contact, organization of cytoplasm, organization of cytoskeleton, formation of cellular protrusions, microtubule dynamics, neuritogenesis, formation of actin, and cell migration (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>, all p-values &lt;0.001). Ingenuity Pathway Analysis&#x2019;s Canonical Pathways also revealed both different and overlapping signals in our DEGs. The most significant Canonical Pathways were oxidative phosphorylation, mitochondrial dysfunction, and protein kinase A signaling; cell-cell junction as well as endothelin-1 signaling were also significant in our data set (all p-values &lt;0.001) (see <xref ref-type="supplementary-material" rid="SM4">
<bold>Supplementary File 4</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Statistically significant gene ontology (GO) analyses of the identified DEGs, as visualized by bubble plots. <bold>(A)</bold> Cell component GO reveals that the most statistically significant categories include intracellular, cytoplasm, and cell junction (q=0.00013 for each); this shows that most protein products DEGs will localize to these cellular compartments. <bold>(B)</bold> Biological processes analysis shows that cell component organization, nervous system development, cytoskeletal organization, and supramolecular fiber organization are amongst the most statistically significant processes (q&#x2264;0.0018), while more specific categories like cytoskeletal organization, biological adhesion, actin filament-based processes, were also identified. In both panels all categories listed are supported by q&#x2264;0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1090081-g004.tif"/>
</fig>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Ingenuity pathway analysis of significant cellular pathways. In this diagram unique genes identified are the outside of the circle, and connected to statistically significant processes (p&lt;0.001). Note the overlap of the biological processes highlighted in purple boxes, which are correlated to dynamics of the cytoskeleton and cytoplasm, cell adhesion, cell morphology, and cell migration.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1090081-g005.tif"/>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Immunofluorescence demonstrates thyroid-dependent changes in cell junction components of the VZ</title>
<p>To corroborate the RNA-Seq findings, we next performed immunofluorescence to visualize components of the extracellular matrix, cytoskeleton, and cell junctions at the VZ in PN2 littermates. We first investigated collagen IV (COL IV), a critical extracellular matrix protein that maintains the basement membrane in brain endothelial cells. One collagen IV subunit was downregulated in our RNA-Seq data (<italic>Col4a6</italic>), and another was downregulated and approaching statistical significance (<italic>Col4a5</italic>, see <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary File 1</bold>
</xref>). Our results in control pups show COL IV is highly expressed at the brain barriers, including in the choroid plexus (blood-cerebrospinal fluid barrier) and in the blood vessels of the VZ (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A, B, D</bold>
</xref>, for colorblind compatible images see <xref ref-type="supplementary-material" rid="SF2">
<bold>Supplementary Figure&#xa0;2</bold>
</xref>). Expression was also observed near the apical surface of the inferior VZ (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>). In contrast to euthyroid controls, PTU exposed pups show pronounced differences in the pattern of COL IV expression, specifically a notable reduction in the vasculature throughout the VZ (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6C, E</bold>
</xref> and <xref ref-type="supplementary-material" rid="SF3">
<bold>Supplementary Figures&#xa0;3A&#x2013;C</bold>
</xref>, see white arrows). Next, we visualized components of the cytoskeleton, given the RNA-Seq signal related to its formation and function. Filamentous actin (F-actin) was visualized by phalloidin staining in PN2 littermates. In euthyroid controls, F-actin is normally distributed throughout the brain, including in the VZ and its associated blood vessels (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6F, H</bold>
</xref> and <xref ref-type="supplementary-material" rid="SF3">
<bold>Supplementary Figure&#xa0;3D</bold>
</xref>). In hypothyroid neonates, F-actin expression appeared globally reduced, and with a more punctate staining patterns as compared to controls (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6G, I</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3E</bold>
</xref>). This was apparent along the entire VZ (inferior, superior, and medial) and in the surrounding parenchyma (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6G, I</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;3D, E</bold>
</xref>). This change in F-actin is reminiscent of the T4 and rT3-dependent change in actin polymerization, which has been reported in neurons and astrocytes <italic>in vitro</italic> and <italic>ex vivo</italic> by others (<xref ref-type="bibr" rid="B29">29</xref>&#x2013;<xref ref-type="bibr" rid="B34">34</xref>). We next examined vimentin (VIM) immunostaining, another component of the cytoskeleton. Vimentin is an intermediate filament and used to visualize radial glial progenitor cells. Radial glia progenitors originate from neuroepithelial cells of the VZ, and anchor endfeet to this region (<xref ref-type="bibr" rid="B13">13</xref>). In our RNA-Seq dataset <italic>Vim</italic> was reduced in PTU exposed pups and this change was approaching statistical significance (q=0.06); <italic>Pax6</italic>, a transcription factor expressed by radial glia, was also downregulated (q=0.06, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary File 1</bold>
</xref>). Our results show that VIM is highly expressed in the PN2 control brain, with pronounced staining of radial glia cells as expected (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>). At high magnification, the spindle-like morphology of radial glial cells is clearly observed, including their attachment to the VZ (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>). In hypothyroid pups, VIM was still observed throughout the brain, although the apicobasal polarity of radial glial cells was abnormal (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>). This was clear at high magnification (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Developmental hypothyroidism affects collagen IV (COL IV) and filamentous actin (F-actin) in PN2 neonates <bold>(A)</bold> Representative regions of the posterior telencephalon. The white bonding boxes represent the inferior and superior portions of the VZ, and represent where the images were captured. Note that the choroid plexus (C.P., blood-cerebrospinal fluid barrier) is in proximity to the VZ and thus often imaged simultaneously. <bold>(B)</bold> Collagen IV (COL IV) is an extracellular matrix protein that is critical to basement membrane maintenance in cerebral endothelial and in some epithelial cells, and was implicated by RNA-Seq. In control pups, COL IV is enriched in blood vessels (B.V.) of the inferior VZ, as well as the vascular component of the choroid plexus. Less pronounced staining is also observed in the more luminal area of the VZ. <bold>(C)</bold> In PTU exposed pups, there was a clear disorganization of COL IV in the blood vessels, the choroid plexus, and in the inferior VZ parenchyma (see arrows). <bold>(D)</bold> COL IV is expressed in the blood vessels and choroid plexus of the superior VZ. <bold>(E)</bold> In PTU exposed pups COL IV also appears reduced in the superior VZ. <bold>(F)</bold> Visualization of F-actin by phalloidin shows strong signal throughout the brain, including in the blood vessels of the inferior VZ. F-actin was also highly enriched surrounding the nuclei of cells (blue DAPI staining) in the VZ, as expected. <bold>(G)</bold> In the PTU exposed animals, staining appeared globally reduced, which was especially notable in the parenchymal cells surrounding the VZ as well as in blood vessels (see arrows). <bold>(H)</bold> F-actin is highly expressed in the superior VZ and its associated blood vessels in control animals. <bold>(I)</bold> The PTU-associated changes in F-actin are apparent in the VZ and the surrounding parenchna. In all panels VZ, ventricular zone; C.P., choroid plexus; Hp, hippocampus; B.V., blood vessel; Vn, ventricle and scale bars are 50 &#xb5;m.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1090081-g006.tif"/>
</fig>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Radial glia cells and cell adhesion are affected in the newborn VZ. <bold>(A)</bold> Vimentin immunohistochemistry highlights radial glia cells. In control animals radial glia endfeet anchor these cells to the ventricular zone (VZ), as seen at high magnification (see asterisk). <bold>(B)</bold> In PTU exposed pups, there is a loss of the apicobasal polarity of radial glia, which is especially prominent at high magnification (see white arrows). Note that the high magnification image was rotated so that the VZ was viewed horizontally. <bold>(C)</bold> Visualization of adherens junctions by N-cadherin. N-cadherin expression is observed in the VZ, notably along the apical border which faces cerebrospinal fluid. <bold>(D)</bold> In PTU exposed pups on PN2 there is a disorganization of N-Cadherin, especailly along the apical border (see arrows). <bold>(E)</bold> Examination of tight junctions by claudin 5 (CLD5) and endothelial cell by PECAM-1. CLD5 is normally expressed in endothelial cells and is a critical compoenent of the blood-brain and blood-cerebrospinal fluid barriers. It is also expressed along the apical surface of the VZ, similar to N-Cadherin. <bold>(F)</bold> In hypothyroid (PTU exposed) neontates, there was a pronounced reduction and disorganization in CLD5 staining in the choroid plexus (see arrows). There was also subtle changes in CLD5 along the apical surface of the VZ. Interestingly, PECAM-1 was also affected in the choroid plexus, and at the more basal region of the VZ as it transitions to the SVZ (see arrows). In all panels VZ, ventricular zone; C.P., choroid plexus; Hp, hippocampus; B.V., blood vessel; Vn, ventricle, and scale bars are 50 &#xb5;m.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1090081-g007.tif"/>
</fig>
<p>As our data suggested that hypothyroid animals exhibited differences in the components that comprise cell junctions, we next asked whether adhesive proteins were also affected. Adherens junctions are the primary cell junction type of the VZ and are responsible for maintaining normal adhesion of the epithelium, including radial glia. This is supported by our results, where N-cadherin expression is strongly expressed in the VZ, especially along its apical border (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7C</bold>
</xref>, for colorblind compatible images see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;4</bold>
</xref>). In contrast, a loss of both basal and apical N-cadherin staining is observed in PTU exposed pups, including amongst the most luminal cells (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7D</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;4D</bold>
</xref>, see arrows). In addition to adherens junctions, tight (occluding) junctions are crucial for polarization of epithelial cells, and for the normal functioning of the brain barriers. To visualize tight junctions, we examined the distribution of claudin 5 (CLD5). We did not observe any overt changes in the expression patterns of CLD5 in the brain parenchyma of the VZ, except along the apical surface; these changes were not as pronounced as N-cadherin (<xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7E, F</bold>
</xref>). CLD5 was also expressed in the CSF-facing epithelial cells of the choroid plexus (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7E</bold>
</xref>); interestingly, CLD5 expression appeared disorganized in the choroid plexus of PTU exposed neonates.</p>
<p>Next, as our bioinformatic analyses suggested that vascular patterning and/or function may be implicated in our RNA-Seq data, we analyzed the endothelial cell marker platelet endothelial cell adhesion molecule 1 (PECAM-1). PECAM-1 was observed in the vascular component of the choroid plexus, as well as in the brain&#x2019;s blood vessels (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7E</bold>
</xref>). The PECAM-1 pattern at the VZ appeared less complex in PTU exposed pups as compared to controls, which was most apparent at the transition between the VZ-SVZ (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7F</bold>
</xref>). We did not observe any notable changes in the co-labeling of PECAM-1 and CLD5 between hypothyroid and euthyroid pups in the VZ parenchyma. However, the disorganization of normal CLD5/PECAM-1 expression was appreciable in the plexus of PTU exposed neonates (compare merge images of 7E and F, see C.P.). In total, these results showed differences in the expression patterns of extracellular matrix, cytoskeletal, and adhesive proteins within the posterior VZ. Surprisingly, during imaging we also observed clear differences in markers of the BBB (cerebral microvasculature, COL IV, PECAM-1, F-actin), as well as the blood-cerebrospinal fluid barrier (choroid plexus, COL IV, F-actin, PECAM-1, CLD5). It is noted that the choroid plexus data were gathered incidentally during imaging, and the RNA-Seq experiment did not include these cells.</p>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>TH action at the VZ may be mediated by both nongenomic and genomic mechanisms</title>
<p>While we found that thyroid stimulating hormone receptor (<italic>Tshr</italic>) was differentially expressed in the posterior VZ (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>), the potential role of TSH in the VZ is unknown. However, it is expressed in the adult SVZ, suggesting it may be of importance in this region (<xref ref-type="bibr" rid="B35">35</xref>). No known receptor for T4 or T3 was identified as a DEG (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary File 1</bold>
</xref>). Given this lack of transcriptional signal, we chose to evaluate the localization of known T4/T3 receptors <italic>in vivo</italic>. Specifically, we hypothesized that the T4 receptor integrin &#x3b1;v&#x3b2;3 would be highly expressed in the VZ. Integrins are transmembrane adhesion proteins that anchor intracellular F-actin to the extracellular matrix, serving as a cell-matrix junction (<xref ref-type="bibr" rid="B36">36</xref>). They are implicated in not only cell adhesion, but are critical to cell migration. Consistent with this hypothesis, we observed robust immunostaining of integrin &#x3b1;v&#x3b2;3 in the VZ of both control and PTU exposed pups. (<xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8A, B</bold>
</xref>). We also detected its expression in the choroid plexus as well as in other brain compartments (<xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8A, B</bold>
</xref>). We next examined the expression of thyroid receptor isoforms, thyroid receptor alpha 2 and beta 1/2 (TR&#x3b1;2 and TR&#x3b2;1/2). TR&#x3b1;2 and TR&#x3b2;1/2 mediate genomic (nuclear initial action) and nongenomic (extranuclear initial action) TH signaling (see <xref ref-type="bibr" rid="B37">37</xref>), and in addition to integrin &#x3b1;v&#x3b2;3 in the VZ, could explain this region&#x2019;s hormone sensitivity. Both <italic>Thra</italic> and <italic>Thrb</italic> were expressed in microdissected VZ cells although they were not differentially expressed between exposure groups; <italic>Thra</italic> exhibited higher expression as compared to <italic>Thrb</italic> (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary File 1</bold>
</xref>). Using an antibody that recognizes TR&#x3b1;2, the dominant negative isoform highly expressed in the developing rat brain (<xref ref-type="bibr" rid="B38">38</xref>), we showed that TR&#x3b1;2 is expressed in the VZ of both control and PTU exposed pups on PN2 (<xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8C, D</bold>
</xref>). TR&#x3b1;2 was also observed in the hippocampus, as well as in the choroid plexus (<xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8C, D</bold>
</xref>, Hp and C.P.). Next, using an antibody that recognizes TR&#x3b2;1/2, robust expression was also observed in the VZ of both control and PTU exposed animals; the hippocampus, and choroid plexus also showed signal (<xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8E, F</bold>
</xref>). Strikingly, integrin &#x3b1;v&#x3b2;3, TR&#x3b1;2, and TR&#x3b2;1/2 show highly similar distribution in the PN2 telencephalon, including enrichment in the VZ (see <xref ref-type="supplementary-material" rid="SF5">
<bold>Supplementary Figure&#xa0;5</bold>
</xref> for antibody control experiments). Taken together, this suggests that the VZ may be a &#x201c;hotspot&#x201d; of TH action in the developing brain.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Mediators of TH action in PN2 pups. All receptors are visualized by diaminobenzidine (DAB) staining; at low magnification DAB is used alone and high magnification images were taken from sections counterstained with Cresyl violet. <bold>(A)</bold> Integrin &#x3b1;<sub>V</sub>&#x3b2;3 is expressed in the VZ of control and <bold>(B)</bold> PTU exposed pups. Signal was also detected in the hippocampus and choroid plexus. High magnification images of the inferior VZ (see bounding box in panel A) demonstrates enriched expression of integrin &#x3b1;V&#x3b2;3 along the apical border of the VZ and in the choroid plexus (see arrows). <bold>(C)</bold> Thyroid receptor alpha 2 (TR&#x3b1;2) was detected in the VZ of both euthyroid control pups and <bold>(D)</bold> PTU exposed pups. High magnification images show TR&#x3b1;2 staining throughout the VZ and in the choroid plexus (arrows). <bold>(E)</bold> Thyroid receptor beta 1/2 (TR&#x3b2;1/2) was also expressed in the VZ of both control and <bold>(F)</bold> PTU exposed pups, in similar brain compartments as integrin &#x3b1;<sub>V</sub>&#x3b2;3 and TR&#x3b1;2. At high magnification TR&#x3b2;1/2 is also expressed in throughout the VZ and in choroid plexus cells (arrows). In all panels VZ, ventricular zone; C.P., choroid plexus; Hp, hippocampus; B.V., blood vessel; Vn, ventricle and scale bars are 50 &#xb5;m. Low magnification images are stained with DAB alone, and high magnification images counterstained with Cresyl violet.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1090081-g008.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>Neurodevelopment requires tightly coordinated spatiotemporal signaling processes, including those controlled by THs. Here we addressed the hypothesis that the posterior VZ is sensitive to TH action during the neonatal period in the rat. While the anterior and/or entire VZ/SVZ has been studied at different developmental stages including adulthood (<xref ref-type="bibr" rid="B39">39</xref>&#x2013;<xref ref-type="bibr" rid="B44">44</xref>), the posterior VZ has not been investigated in isolation during an established time of TH dependency.</p>
<sec id="s4_1">
<label>4.1</label>
<title>TH action affects components of cell junctions in the ventricular zone</title>
<p>Cell&#x2013;cell junctions link cells to maintain tissue homeostasis, and regulate critical processes like tissue barrier function, cell proliferation, and cell migration. Tight and adherens junctions are two different multiprotein complexes that require similar components: adhesion proteins to physically connect cells, anchoring proteins that link the intercellular cytoskeleton, and an extracellular matrix that supports cell shape and contacts (<xref ref-type="bibr" rid="B45">45</xref>). Perturbation of any of these components can disrupt the structure and function of cell junctions. For example, disruption of CLD5 (adhesion molecule), actin (cytoskeleton), or COL IV (basement membrane, extracellular matrix) in tight junctions of brain endothelial cells will disturb the occluding activity of the BBB (<xref ref-type="bibr" rid="B46">46</xref>&#x2013;<xref ref-type="bibr" rid="B48">48</xref>). In this study we show that various adhesion, cytoskeletal, and extracellular matrix proteins are simultaneously disturbed by moderate developmental hypothyroidism <italic>in vivo</italic>. While these findings may have several implications for the development and function of the brain, it is clear that cell migration is affected.</p>
<p>Our previous work to understand the cellular etiology of the periventricular heterotopia showed that radial glia cells were abnormal in hypothyroid rat pups (<xref ref-type="bibr" rid="B4">4</xref>). We correlated this observation to downregulation of <italic>Spred1</italic>, as detected by qRT-PCR in a hand-dissected region of the brain that included the cortex, hippocampus, and VZ (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B4">4</xref>). Here, using a lower dose of PTU and laser capture microdissection to isolate the VZ in newborn rats, we again demonstrate downregulation of <italic>Spred1</italic> and loss of radial glia apicobasal polarity. Phoenix and Temple (<xref ref-type="bibr" rid="B49">49</xref>) showed that <italic>Spred1</italic> knockdown in the embryonic mouse brain caused reduced cell adhesion at the VZ/SVZ, abnormal morphology of radial glia cells, and disordered neuroblast migration. The authors also detected periventricular heterotopia in the posterior telencephalon of postnatal mice (<xref ref-type="bibr" rid="B49">49</xref>). In patients, periventricular heterotopia are often attributed to mutations in cytoskeletal proteins. The most commonly associated are within filamin A (FLNA), but other genes encoding cytoskeletal, adhesive, and extracellular matrix proteins are also implicated (reviewed in <xref ref-type="bibr" rid="B50">50</xref>). Intriguingly, various COL IV mutations cause not only heterotopia, but also small vessel disease of the brain in affected individuals (<xref ref-type="bibr" rid="B50">50</xref>). Here we also show that TH action affects expression of <italic>Col4a6</italic> (q<italic>=0.04)</italic>, <italic>Col4a5</italic> (q<italic>=0.07)</italic>, and COL IV at the rat VZ. Regardless of the molecular etiology, it is established across species that heterotopia are caused by abnormalities in radial glia-mediated cell migration (<xref ref-type="bibr" rid="B49">49</xref>&#x2013;<xref ref-type="bibr" rid="B52">52</xref>). These observations, coupled with our repeatable findings, strengthens the interpretation that TH action affects radial glia form and function, which then leads to heterotopia formation in the rat.</p>
<p>The conclusion that radial glial cells and/or cell migration can be affected by TH action has been supported by others (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B53">53</xref>&#x2013;<xref ref-type="bibr" rid="B60">60</xref>). There are several hypotheses about why this occurs, including TH-mediated loss of cell adhesion at the VZ, which normally anchors radial glia endfeet (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B59">59</xref>). Other hypotheses include direct changes in the cytoskeleton of radial glia, as F-actin in particular is responsive to T4 and rT3 in the brain (<xref ref-type="bibr" rid="B29">29</xref>&#x2013;<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B61">61</xref>). Given the data presented here, we cannot determine whether abnormalities in adherens junctions of the VZ cause loss of radial glial cell morphology, or if this is a secondary effect of cytoskeletal changes in radial glia themselves. Regardless, loss of adherens junctions in the VZ is associated with loss of radial glia apicobasal polarity, which results in abnormal cell migration in other models (<xref ref-type="bibr" rid="B62">62</xref>). Interestingly, despite the VZ&#x2019;s function as a stem cell niche, we did not detect a robust transcriptional signal related to neurogenesis and/or cell differentiation. For example, we did not detect a downregulation of genes related to oligodendrocyte progenitors (i.e., <italic>Ng2</italic>, <italic>Olig1</italic>, <italic>Olig2</italic>) in PTU exposed animals, even though reduced myelination is well established consequence of hypothyroidism (<xref ref-type="bibr" rid="B1">1</xref>). We acknowledge that bulk RNA-Seq may make such determinations regarding cell population changes difficult (<xref ref-type="bibr" rid="B63">63</xref>). But overall, the RNA-Seq data are supportive of our previous work, where we did not find a significant difference in Ki67+ cells at the ventricular epithelium in PN2 hypothyroid neonates (<xref ref-type="bibr" rid="B4">4</xref>). Neurogenesis in the developing and adult VZ-SVZ has been shown to be affected by THs (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B65">65</xref>), but the majority of published work has examined the anterior or entire VZ and/or SVZ in rodents older than this study. Some cellular biology studies have shown that abnormal cell junctions in the brain precede neurogenesis and cellular differentiation deficits, due to a breakdown in intercellular communication (reviewed in <xref ref-type="bibr" rid="B66">66</xref>). We also show by pathway analysis that oxidative phosphorylation was significantly represented in our RNA-Seq data, and that it was estimated to be activated. Neural progenitor cells switch primarily from glycolysis to oxidative phosphorylation upon differentiation (<xref ref-type="bibr" rid="B67">67</xref>), so it is possible that this transcriptional signal may be another early indicator of abnormal neurogenesis in hypothyroid animals. In the future it would be interesting to determine if and how TH-action may affect cell differentiation in this model of moderate hypothyroidism, but developmental stages later than PN2 should be included.</p>
<p>TH action may influence the cytoskeleton and extracellular matrix of brain tissue by multiple mechanisms (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B31">31</xref>&#x2013;<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B61">61</xref>). With respects to <italic>in vivo</italic> models, Morte et al. reported differential expression of cytoskeletal genes in the brains of hypothyroid rat pups; however, maternal TH function was abolished by thyroidectomy as well as methamizole exposure <xref ref-type="bibr" rid="B68">68</xref>. In a series of <italic>ex vivo</italic> experiments, Farwell et al. showed that deficiency in T4 and rT3 reduced F-actin in rat cerebellar cells, which attenuated neurite migration (<xref ref-type="bibr" rid="B33">33</xref>). This migration phenotype could be recapitulated by blocking the integrin &#x3b2;1 subunit, even in the presence of sufficient T4/rT3 concentrations. This suggests that that the hormonal regulation of F-actin is necessary for normal integrin &#x3b2;1-mediated cell migration (<xref ref-type="bibr" rid="B33">33</xref>). With respects to this study, brain T4 was significantly reduced although rT3 was more variable between rat pups across litters. Integrin &#x3b1;v&#x3b2;3 protein was also expressed in the developing rat VZ. Similar to <italic>in vitro</italic> and <italic>ex vivo</italic> reports, we demonstrated that F-actin appeared reduced and our model suffers from abnormal cell migration as evidenced by periventricular heterotopia formation (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B5">5</xref>&#x2013;<xref ref-type="bibr" rid="B8">8</xref>). Thus, the similarities between experimental models are compelling and suggests the brain cytoskeleton can be perturbed by moderate hypothyroidism <italic>in vivo</italic>. In the future, additional studies are needed to fully elucidate the TH signaling mechanism(s) at the VZ and how this translates to the observed cellular abnormalities. This could include rescue experiments where T4/T3 are each supplemented to hypothyroid pups and gene expression measured at the VZ, chromatin immunoprecipitation of thyroid receptors, and/or pharmacological manipulation of integrin &#x3b1;v&#x3b2;3.</p>
</sec>
<sec id="s4_2">
<label>4.2</label>
<title>TH action and the blood-brain and blood-cerebrospinal fluid barriers</title>
<p>We previously hypothesized that the VZ was susceptible to TH action, due to its juxtaposition between two sources of brain THs: the CSF and an enriched vascular network (<xref ref-type="bibr" rid="B4">4</xref>). The VZ itself also represents the developmentally transient CSF-brain barrier (<xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B70">70</xref>). What we did not expect to discover was that the TH-dependent changes in the VZ parenchyma may also extended to cerebral endothelial cells.</p>
<p>The blood-brain and blood-CSF barriers develop in parallel with the brain tissue, and these fluid interfaces are functional during fetal development (<xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B72">72</xref>). These mechanical and physiological barriers are comprised of tight and adherens junctions that line endothelial cells of the central nervous system, expression and activity of influx and efflux transporters, and fluid flux-flow dynamics (<xref ref-type="bibr" rid="B73">73</xref>). However, tight junctions are the hallmark of their occluding activity. In our RNA-Seq experiment, we sequenced all cell types within microdissected VZ, which represents a heterogeneous population. We subsequently identified several DEGs that are critical to brain barrier function (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>); microscopy also revealed pronounced effects in endothelial cells of the brain vasculature and/or choroid plexus, in addition to changes in VZ parenchyma. Specifically, COL IV, F-actin, CLD5, and PECAM-1 are associated with endothelial cell patterning and/or function of the BBB <italic>in vivo</italic> (<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B74">74</xref>, <xref ref-type="bibr" rid="B75">75</xref>), and we discovered clear effects in their localization between euthyroid and hypothyroid neonates. These preliminary findings pose the new question &#x2013; could brain barrier development and/or function be an underappreciated target of TH action?</p>
<p>Several studies in adult and canines demonstrate that hypothyroidism is associated with increased permeability of the brain barriers (<xref ref-type="bibr" rid="B76">76</xref>&#x2013;<xref ref-type="bibr" rid="B81">81</xref>). Clinically, this manifests as increased protein concentrations in the CSF. In one study, necropsy of affected hypothyroid dogs suggested cerebrovascular disease in this species (<xref ref-type="bibr" rid="B80">80</xref>). More than half a century ago, Thompson et al. studied 17 adult patients with myxedema, who also presented with increased CSF protein concentrations (<xref ref-type="bibr" rid="B76">76</xref>). Amazingly, after supplementation with thyroid extract all but 2 patients had a marked reduction in CSF protein content, and achieved normal levels once euthyroidism was established (<xref ref-type="bibr" rid="B76">76</xref>). This rescue to a normal phenotype demonstrates that brain barrier function directly responds to TH action. While the mechanisms of these observations are unknown, TH signaling can affect vascular function and patterning in different tissues. This has been shown <italic>in vitro</italic> and <italic>in vivo</italic> with regards to T4/rT3 action on integrin &#x3b1;v&#x3b2;3 (reviewed in Davis et&#xa0;al., 2020), as well as TSH activity <italic>via</italic> TSHR in primary human cultures (<xref ref-type="bibr" rid="B82">82</xref>). Both pathways appear to be proangiogenic, where both excess T4 or TSH can induce angiogenesis (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B82">82</xref>). It has also been shown in rats exposed to PTU from birth to PN21 that brain angiogenesis was reduced, including in the complexity and density of microvessels (<xref ref-type="bibr" rid="B83">83</xref>). Taken together, there is evidence that THs control the morphogenesis and function of endothelial cells, and this is likely mediated by multiple complex mechanisms. While there is convincing evidence that thyroid-mediated brain barrier disruption in adults is transient and corrects following TH supplementation, this may not occur during development. If TH action controls patterning of cells that comprise the brain barriers, then it is possible that developmental hypothyroidism could lead to permanent changes in the way the barriers are formed and/or function. Future studies should determine if TH action can affect brain barrier activity, and if so, determine its persistence. There is accumulating evidence that both neurodevelopmental and neurodegenerative disorders are associated with increased permeability of the BBB (<xref ref-type="bibr" rid="B84">84</xref>), so any TH-mediated effects could have significant consequences.</p>
</sec>
<sec id="s4_3">
<label>4.3</label>
<title>The human health implications of this study</title>
<p>This study extends our previous observations and reinforces that TH action targets multiple components of normal cell junctions in the developing brain. These abnormalities can converge to affect downstream processes like cell migration and potentially brain barrier function. While previous <italic>in vivo</italic> work has demonstrated that radial glia morphology and/or cell migration is affected by developmental hypothyroidism, these conclusions were drawn from experiments that induced severe TH disturbances (e.g., maternal thyroidectomy and/or high doses of TH modulators) (<xref ref-type="bibr" rid="B53">53</xref>&#x2013;<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>). While these studies are critical to our understanding of mechanisms, it can be difficult to translate these findings to patients. Our PTU exposed dams exhibited a relatively minor 72% increase in TSH, with no significant change in serum T3. The American Thyroid Association advises that normal TSH in pregnant patients during the second trimester is 0.2-3.0 mIU/L in absence of a laboratory-established reference range (<xref ref-type="bibr" rid="B85">85</xref>). Given the biological variability of TSH in human populations and our presented data, we consider our experiment representative of moderate maternal hypothyroidism. The pronounced effects we observed at the neonatal VZ, with the knowledge that a 3 ppm PTU exposure will induce a periventricular heterotopia in offspring (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>), emphasizes that euthyroidism throughout pregnancy is critical. The mammalian brain undergoes protracted development, so processes like cell migration occur over many weeks in both human and rodents (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B86">86</xref>).</p>
<p>In conclusion, this study provides evidence that the posterior VZ is sensitive to THs in newborn rats, even under conditions of moderate maternal hypothyroidism. Specifically, components of normal cell junctions including adhesive, cytoskeletal, and extracellular matrix transcripts were differentially expressed as detected by RNA-Seq and pathway analyses. Immunofluorescence reinforced these results, and supports that cell migration is a target of TH action. In addition, this work led to the unexpected finding that components of both the blood-brain and blood-cerebrospinal fluid barrier may also be affected by hypothyroidism. While we acknowledge our study&#x2019;s limitations, namely that there are multiple cell types in this the developing VZ and we performed bulk RNA-Seq, these findings support previous hypotheses that cell adhesion and radial glia cell polarity are affected in this critical region. In the future, single cell RNA-Seq to differentiate between various cell types in the VZ (i.e., radial glia versus endothelia cells), and functional studies of brain barrier function could further illuminate mechanisms of TH action.</p>
</sec>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>All raw data for hormone analyses can be found in the public repository Science Hub. The sequencing data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus (<xref ref-type="bibr" rid="B87">87</xref>) and are accessible through GEO Series accession number GSE218930 (<uri xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE218930">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE218930</uri>).</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>All experiments were conducted with prior approval from the United States Environmental Protection Agency&#x2019;s (US EPA&#x2019;s) Institutional Animal Care and Usage Committee and were carried out in an Association for Assessment and Accreditation of Laboratory Animal Care approved facility.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>KO conceived and executed the study, performed sectioning, laser capture microdissection, library preparations, bioinformatics, microscopy, prepared figures, and wrote the article. AS performed sectioning and immunohistochemistry. BM assisted with bioinformatics. KB and MG assisted with the animal exposure. CR, JF, and RG measured thyroid hormones. TS provided equipment, and AP also provided equipment and training for laser capture microdissection. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by US EPA&#x2019;s Office of Research and Development and Division of the National Toxicology Program at the National Institute of Environmental Health Sciences.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>The authors thank Drs. Andrew Johnstone and Emily Pitzer for their comments on previous versions of this manuscript.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Author disclaimer</title>
<p>This document has been subjected to review by the Center for Public Health and Environmental Assessment and approved for publication. Approval does not signify that the contents reflect the views of the Agency, nor does mention of trade names or commercial products constitute endorsement or recommendation for use.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2023.1090081/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fendo.2023.1090081/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image_1.jpg" id="SF1" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_2.jpg" id="SF2" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_3.jpeg" id="SF3" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_4.jpg" id="SF4" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_5.jpg" id="SF5" mimetype="image/jpeg"/>
<supplementary-material xlink:href="DataSheet_1.xls" id="SM1" mimetype="application/vnd.ms-excel"/>
<supplementary-material xlink:href="DataSheet_2.xlsx" id="SM2" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="DataSheet_3.xlsx" id="SM3" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="DataSheet_4.xlsx" id="SM4" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Table_1.docx" id="ST1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Bernal</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Thyroid hormones in brain development and function</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>De Groot</surname> <given-names>LJ</given-names>
</name>
<name>
<surname>Beck-Peccoz</surname> <given-names>GCP</given-names>
</name>
<name>
<surname>Dungan</surname> <given-names>K</given-names>
</name>
<name>
<surname>Grossman</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hershman</surname> <given-names>JM</given-names>
</name>
<name>
<surname>C. Koch</surname> <given-names>R</given-names>
</name>
<name>
<surname>McLachlan</surname> <given-names>MN</given-names>
</name>
<name>
<surname>Rebar</surname> <given-names>R</given-names>
</name>
<name>
<surname>Singer</surname> <given-names>F</given-names>
</name>
<name>
<surname>Vinik</surname> <given-names>A</given-names>
</name>
<name>
<surname>Weickert</surname> <given-names>MO</given-names>
</name>
</person-group>, editors. <source>Endotext</source>. <publisher-loc>South Dartmouth (MA</publisher-loc>: <publisher-name>MDText.com, Inc</publisher-name> (<year>2015</year>).</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Shaughnessy</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Gilbert</surname> <given-names>ME</given-names>
</name>
</person-group>. <article-title>Thyroid disrupting chemicals and developmental neurotoxicity - new tools and approaches to evaluate hormone action</article-title>. <source>Mol Cell Endocrinol</source> (<year>2019</year>) <volume>518</volume>:<elocation-id>110663</elocation-id>, <fpage>110663</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mce.2019.110663</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Shaughnessy</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Kosian</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Ford</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Oshiro</surname> <given-names>WM</given-names>
</name>
<name>
<surname>Degitz</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Gilbert</surname> <given-names>ME</given-names>
</name>
</person-group>. <article-title>Developmental thyroid hormone insufficiency induces a cortical brain malformation and learning impairments: A cross-fostering study</article-title>. <source>Toxicol Sci</source> (<year>2018</year>) <volume>163</volume>(<issue>1</issue>):<page-range>101&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/toxsci/kfy016</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Shaughnessy</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Thomas</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Spring</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Ford</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Ford</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Gilbert</surname> <given-names>ME</given-names>
</name>
</person-group>. <article-title>A transient window of hypothyroidism alters neural progenitor cells and results in abnormal brain development</article-title>. <source>Sci Rep</source> (<year>2019</year>) <volume>9</volume>(<issue>1</issue>):<fpage>4662</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-019-40249-7</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodman</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Gilbert</surname> <given-names>ME</given-names>
</name>
</person-group>. <article-title>Modest thyroid hormone insufficiency during development induces a cellular malformation in the corpus callosum: A model of cortical dysplasia</article-title>. <source>Endocrinology</source> (<year>2007</year>) <volume>148</volume>(<issue>6</issue>):<page-range>2593&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2006-1276</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilbert</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Ramos</surname> <given-names>RL</given-names>
</name>
<name>
<surname>McCloskey</surname> <given-names>DP</given-names>
</name>
<name>
<surname>Goodman</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>Subcortical band heterotopia in rat offspring following maternal hypothyroxinaemia: Structural and functional characteristics</article-title>. <source>J Neuroendocrinol</source> (<year>2014</year>) <volume>26</volume>(<issue>8</issue>):<page-range>528&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jne.12169</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spring</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Bastian</surname> <given-names>TW</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kosian</surname> <given-names>P</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>GW</given-names>
</name>
<name>
<surname>Gilbert</surname> <given-names>ME</given-names>
</name>
</person-group>. <article-title>Thyroid hormone-dependent formation of a subcortical band heterotopia (SBH) in the neonatal brain is not exacerbated under conditions of low dietary iron (FeD)</article-title>. <source>Neurotoxicol Teratol</source> (<year>2016</year>) <volume>56</volume>:<page-range>41&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ntt.2016.05.007</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramhoj</surname> <given-names>L</given-names>
</name>
<name>
<surname>Fradrich</surname> <given-names>C</given-names>
</name>
<name>
<surname>Svingen</surname> <given-names>T</given-names>
</name>
<name>
<surname>Scholze</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wirth</surname> <given-names>EK</given-names>
</name>
<name>
<surname>Rijntjes</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Testing for heterotopia formation in rats after developmental exposure to selected <italic>in vitro</italic> inhibitors of thyroperoxidase</article-title>. <source>Environ pollut</source> (<year>2021</year>) <volume>283</volume>:<elocation-id>117135</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.envpol.2021.117135</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minami</surname> <given-names>K</given-names>
</name>
<name>
<surname>Suto</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sato</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ogata</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kosaka</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hojo</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Feasibility study for a downsized comparative thyroid assay with measurement of brain thyroid hormones and histopathology in rats: Case study with 6-propylthiouracil and sodium phenobarbital at high dose</article-title>. <source>Regul Toxicol Pharmacol</source> (<year>2022</year>) <volume>137</volume>:<elocation-id>105283</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.yrtph.2022.105283</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hansen</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Siersbaek-Nielsen</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Cerebrospinal fluid thyroxine</article-title>. <source>J Clin Endocrinol Metab</source> (<year>1969</year>) <volume>29</volume>(<issue>8</issue>):<page-range>1023&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/jcem-29-8-1023</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernal</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>The significance of thyroid hormone transporters in the brain</article-title>. <source>Endocrinology</source> (<year>2005</year>) <volume>146</volume>(<issue>4</issue>):<page-range>1698&#x2013;700</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2005-0134</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noctor</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Flint</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Weissman</surname> <given-names>TA</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>WS</given-names>
</name>
<name>
<surname>Clinton</surname> <given-names>BK</given-names>
</name>
<name>
<surname>Kriegstein</surname> <given-names>AR</given-names>
</name>
</person-group>. <article-title>Dividing precursor cells of the embryonic cortical ventricular zone have morphological and molecular characteristics of radial glia</article-title>. <source>J Neurosci</source> (<year>2002</year>) <volume>22</volume>(<issue>8</issue>):<page-range>3161&#x2013;73</page-range>. doi:&#xa0;20026299
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tramontin</surname> <given-names>AD</given-names>
</name>
<name>
<surname>Garcia-Verdugo</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Alvarez-Buylla</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Postnatal development of radial glia and the ventricular zone (VZ): A continuum of the neural stem cell compartment</article-title>. <source>Cereb Cortex</source> (<year>2003</year>) <volume>13</volume>(<issue>6</issue>):<page-range>580&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cercor/13.6.580</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noctor</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Martinez-Cerdeno</surname> <given-names>V</given-names>
</name>
<name>
<surname>Ivic</surname> <given-names>L</given-names>
</name>
<name>
<surname>Kriegstein</surname> <given-names>AR</given-names>
</name>
</person-group>. <article-title>Cortical neurons arise in symmetric and asymmetric division zones and migrate through specific phases</article-title>. <source>Nat Neurosci</source> (<year>2004</year>) <volume>7</volume>(<issue>2</issue>):<page-range>136&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nn1172</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>SX</given-names>
</name>
<name>
<surname>Goebbels</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>K</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kometani</surname> <given-names>K</given-names>
</name>
<name>
<surname>Minato</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Pyramidal neurons of upper cortical layers generated by NEX-positive progenitor cells in the subventricular zone</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2005</year>) <volume>102</volume>(<issue>47</issue>):<page-range>17172&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0508560102</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petros</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Bultje</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Ross</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Fishell</surname> <given-names>G</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>SA</given-names>
</name>
</person-group>. <article-title>Apical versus basal neurogenesis directs cortical interneuron subclass fate</article-title>. <source>Cell Rep</source> (<year>2015</year>) <volume>13</volume>(<issue>6</issue>):<page-range>1090&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2015.09.079</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mellert</surname> <given-names>W</given-names>
</name>
<name>
<surname>Deckardt</surname> <given-names>K</given-names>
</name>
<name>
<surname>Walter</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gfatter</surname> <given-names>S</given-names>
</name>
<name>
<surname>van Ravenzwaay</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Detection of endocrine-modulating effects of the antithyroid acting drug 6-propyl-2-thiouracil in rats, based on the "Enhanced OECD test guideline 407</article-title>. <source>Regul Toxicol Pharmacol</source> (<year>2003</year>) <volume>38</volume>(<issue>3</issue>):<page-range>368&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.yrtph.2003.07.003</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bansal</surname> <given-names>R</given-names>
</name>
<name>
<surname>Zoeller</surname> <given-names>RT</given-names>
</name>
</person-group>. <article-title>CLARITY-BPA: Bisphenol a or propylthiouracil on thyroid function and effects in the developing Male and female rat brain</article-title>. <source>Endocrinology</source> (<year>2019</year>) <volume>160</volume>(<issue>8</issue>):<page-range>1771&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2019-00121</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilbert</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Hassan</surname> <given-names>I</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>C</given-names>
</name>
<name>
<surname>O'Shaughnessy</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Spring</surname> <given-names>S</given-names>
</name>
<name>
<surname>Thomas</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Gestational exposure to perchlorate in the rat: Thyroid hormones in fetal thyroid gland, serum, and brain</article-title>. <source>Toxicol Sci</source> (<year>2022</year>) <volume>188</volume>(<issue>1</issue>):<page-range>117&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/toxsci/kfac038</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolger</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Lohse</surname> <given-names>M</given-names>
</name>
<name>
<surname>Usadel</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Trimmomatic: A flexible trimmer for illumina sequence data</article-title>. <source>Bioinformatics</source> (<year>2014</year>) <volume>30</volume>(<issue>15</issue>):<page-range>2114&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/btu170</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Love</surname> <given-names>MI</given-names>
</name>
<name>
<surname>Huber</surname> <given-names>W</given-names>
</name>
<name>
<surname>Anders</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol</source> (<year>2014</year>) <volume>15</volume>(<issue>12</issue>):<elocation-id>550</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Wickham</surname> <given-names>H</given-names>
</name>
</person-group>. <source>ggplot2: Elegant graphics for data analysis</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer-Verlag</publisher-name> (<year>2016</year>).</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolde</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Pheatmap: pretty heatmaps</article-title>. <source>R Package version</source> (<year>2012</year>) <volume>1</volume>(<issue>2</issue>):<fpage>726</fpage>.</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Garnier</surname> <given-names>S</given-names>
</name>
<name>
<surname>Noam</surname> <given-names>R</given-names>
</name>
<name>
<surname>Rudis</surname> <given-names>R</given-names>
</name>
<name>
<surname>Sciaini</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pedro Camargo</surname> <given-names>A</given-names>
</name>
<name>
<surname>Scherer</surname> <given-names>C</given-names>
</name>
</person-group>. <source>Viridis - colorblind-friendly color maps for r</source> (<year>2021</year>). Available at: <uri xlink:href="https://sjmgarnier.github.io/viridis/">https://sjmgarnier.github.io/viridis/</uri>.</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szklarczyk</surname> <given-names>D</given-names>
</name>
<name>
<surname>Gable</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Lyon</surname> <given-names>D</given-names>
</name>
<name>
<surname>Junge</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wyder</surname> <given-names>S</given-names>
</name>
<name>
<surname>Huerta-Cepas</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets</article-title>. <source>Nucleic Acids Res</source> (<year>2019</year>) <volume>47</volume>(<issue>D1</issue>):<page-range>D607&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gky1131</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hutton</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Pevny</surname> <given-names>LH</given-names>
</name>
</person-group>. <article-title>SOX2 expression levels distinguish between neural progenitor populations of the developing dorsal telencephalon</article-title>. <source>Dev Biol</source> (<year>2011</year>) <volume>352</volume>(<issue>1</issue>):<page-range>40&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ydbio.2011.01.015</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Royland</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Parker</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Gilbert</surname> <given-names>ME</given-names>
</name>
</person-group>. <article-title>A genomic analysis of subclinical hypothyroidism in hippocampus and neocortex of the developing rat brain</article-title>. <source>J Neuroendocrinol</source> (<year>2008</year>) <volume>20</volume>(<issue>12</issue>):<page-range>1319&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2826.2008.01793.x</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Shaughnessy</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Ford</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Kosian</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Hotchkiss</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Degitz</surname> <given-names>SJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Thyroid hormone disruption in the fetal and neonatal rat: Predictive hormone measures and bioindicators of hormone action in the developing cortex</article-title>. <source>Toxicol Sci</source> (<year>2018</year>) <volume>166</volume>(<issue>1</issue>):<page-range>163&#x2013;79</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/toxsci/kfy190</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farwell</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Lynch</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Okulicz</surname> <given-names>WC</given-names>
</name>
<name>
<surname>Comi</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Leonard</surname> <given-names>JL</given-names>
</name>
</person-group>. <article-title>The actin cytoskeleton mediates the hormonally regulated translocation of type II iodothyronine 5'-deiodinase in astrocytes</article-title>. <source>J Biol Chem</source> (<year>1990</year>) <volume>265</volume>(<issue>30</issue>):<page-range>18546&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0021-9258(17)44786-7</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siegrist-Kaiser</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Juge-Aubry</surname> <given-names>C</given-names>
</name>
<name>
<surname>Tranter</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Ekenbarger</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Leonard</surname> <given-names>JL</given-names>
</name>
</person-group>. <article-title>Thyroxine-dependent modulation of actin polymerization in cultured astrocytes. a novel, extranuclear action of thyroid hormone</article-title>. <source>J Biol Chem</source> (<year>1990</year>) <volume>265</volume>(<issue>9</issue>):<page-range>5296&#x2013;302</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0021-9258(19)34121-3</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farwell</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Leonard</surname> <given-names>JL</given-names>
</name>
</person-group>. <article-title>Dissociation of actin polymerization and enzyme inactivation in the hormonal regulation of type II iodothyronine 5'-deiodinase activity in astrocytes</article-title>. <source>Endocrinology</source> (<year>1992</year>) <volume>131</volume>(<issue>2</issue>):<page-range>721&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/endo.131.2.1322280</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farwell</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Tranter</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Leonard</surname> <given-names>JL</given-names>
</name>
</person-group>. <article-title>Thyroxine-dependent regulation of integrin-laminin interactions in astrocytes</article-title>. <source>Endocrinology</source> (<year>1995</year>) <volume>136</volume>(<issue>9</issue>):<page-range>3909&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/endo.136.9.7649099</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farwell</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Dubord-Tomasetti</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Pietrzykowski</surname> <given-names>AZ</given-names>
</name>
<name>
<surname>Stachelek</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Leonard</surname> <given-names>JL</given-names>
</name>
</person-group>. <article-title>Regulation of cerebellar neuronal migration and neurite outgrowth by thyroxine and 3,3',5'-triiodothyronine</article-title>. <source>Brain Res Dev Brain Res</source> (<year>2005</year>) <volume>154</volume>(<issue>1</issue>):<page-range>121&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.devbrainres.2004.07.016</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farwell</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Dubord-Tomasetti</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Pietrzykowski</surname> <given-names>AZ</given-names>
</name>
<name>
<surname>Leonard</surname> <given-names>JL</given-names>
</name>
</person-group>. <article-title>Dynamic nongenomic actions of thyroid hormone in the developing rat brain</article-title>. <source>Endocrinology</source> (<year>2006</year>) <volume>147</volume>(<issue>5</issue>):<page-range>2567&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2005-1272</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crisanti</surname> <given-names>P</given-names>
</name>
<name>
<surname>Omri</surname> <given-names>B</given-names>
</name>
<name>
<surname>Hughes</surname> <given-names>E</given-names>
</name>
<name>
<surname>Meduri</surname> <given-names>G</given-names>
</name>
<name>
<surname>Hery</surname> <given-names>C</given-names>
</name>
<name>
<surname>Clauser</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>The expression of thyrotropin receptor in the brain</article-title>. <source>Endocrinology</source> (<year>2001</year>) <volume>142</volume>(<issue>2</issue>):<page-range>812&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/endo.142.2.7943</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Mousa</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>HY</given-names>
</name>
</person-group>. <article-title>Nongenomic actions of thyroid hormone: The integrin component</article-title>. <source>Physiol Rev</source> (<year>2021</year>) <volume>101</volume>(<issue>1</issue>):<page-range>319&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/physrev.00038.2019</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flamant</surname> <given-names>F</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Hollenberg</surname> <given-names>AN</given-names>
</name>
<name>
<surname>Moeller</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Samarut</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wondisford</surname> <given-names>FE</given-names>
</name>
<etal/>
</person-group>. <article-title>Thyroid hormone signaling pathways: Time for a more precise nomenclature</article-title>. <source>Endocrinology</source> (<year>2017</year>) <volume>158</volume>(<issue>7</issue>):<page-range>2052&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2017-00250</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strait</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Schwartz</surname> <given-names>HL</given-names>
</name>
<name>
<surname>Perez-Castillo</surname> <given-names>A</given-names>
</name>
<name>
<surname>Oppenheimer</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>Relationship of c-erbA mRNA content to tissue triiodothyronine nuclear binding capacity and function in developing and adult rats</article-title>. <source>J Biol Chem</source> (<year>1990</year>) <volume>265</volume>(<issue>18</issue>):<page-range>10514&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0021-9258(18)86977-0</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez-Juarez</surname> <given-names>A</given-names>
</name>
<name>
<surname>Remaud</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hassani</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Jolivet</surname> <given-names>P</given-names>
</name>
<name>
<surname>Pierre Simons</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sontag</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Thyroid hormone signaling acts as a neurogenic switch by repressing Sox2 in the adult neural stem cell niche</article-title>. <source>Cell Stem Cell</source> (<year>2012</year>) <volume>10</volume>(<issue>5</issue>):<page-range>531&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.stem.2012.04.008</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stenzel</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wilsch-Brauninger</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>FK</given-names>
</name>
<name>
<surname>Heuer</surname> <given-names>H</given-names>
</name>
<name>
<surname>Huttner</surname> <given-names>WB</given-names>
</name>
</person-group>. <article-title>Integrin alphavbeta3 and thyroid hormones promote expansion of progenitors in embryonic neocortex</article-title>. <source>Development</source> (<year>2014</year>) <volume>141</volume>(<issue>4</issue>):<fpage>795</fpage>&#x2013;<lpage>806</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/dev.101907</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Remaud</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ortiz</surname> <given-names>FC</given-names>
</name>
<name>
<surname>Perret-Jeanneret</surname> <given-names>M</given-names>
</name>
<name>
<surname>Aigrot</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Gothie</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Fekete</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Transient hypothyroidism favors oligodendrocyte generation providing functional remyelination in the adult mouse brain</article-title>. <source>Elife</source> (<year>2017</year>) <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.29996</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vancamp</surname> <given-names>P</given-names>
</name>
<name>
<surname>Gothie</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Luongo</surname> <given-names>C</given-names>
</name>
<name>
<surname>Sebillot</surname> <given-names>A</given-names>
</name>
<name>
<surname>Le Blay</surname> <given-names>K</given-names>
</name>
<name>
<surname>Butruille</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Gender-specific effects of transthyretin on neural stem cell fate in the subventricular zone of the adult mouse</article-title>. <source>Sci Rep</source> (<year>2019</year>) <volume>9</volume>(<issue>1</issue>):<fpage>19689</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-019-56156-w</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luongo</surname> <given-names>C</given-names>
</name>
<name>
<surname>Butruille</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sebillot</surname> <given-names>A</given-names>
</name>
<name>
<surname>Le Blay</surname> <given-names>K</given-names>
</name>
<name>
<surname>Schwaninger</surname> <given-names>M</given-names>
</name>
<name>
<surname>Heuer</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Absence of both thyroid hormone transporters MCT8 and OATP1C1 impairs neural stem cell fate in the adult mouse subventricular zone</article-title>. <source>Stem Cell Rep</source> (<year>2021</year>) <volume>16</volume>(<issue>2</issue>):<page-range>337&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.stemcr.2020.12.009</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vancamp</surname> <given-names>P</given-names>
</name>
<name>
<surname>Le Blay</surname> <given-names>K</given-names>
</name>
<name>
<surname>Butruille</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sebillot</surname> <given-names>A</given-names>
</name>
<name>
<surname>Boelen</surname> <given-names>A</given-names>
</name>
<name>
<surname>Demeneix</surname> <given-names>BA</given-names>
</name>
<etal/>
</person-group>. <article-title>Developmental thyroid disruption permanently affects the neuroglial output in the murine subventricular zone</article-title>. <source>Stem Cell Rep</source> (<year>2022</year>) <volume>17</volume>(<issue>3</issue>):<page-range>459&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.stemcr.2022.01.002</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adil</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Narayanan</surname> <given-names>SP</given-names>
</name>
<name>
<surname>Somanath</surname> <given-names>PR</given-names>
</name>
</person-group>. <article-title>Cell-cell junctions: structure and regulation in physiology and pathology</article-title>. <source>Tissue Barriers</source> (<year>2021</year>) <volume>9</volume>(<issue>1</issue>):<elocation-id>1848212</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21688370.2020.1848212</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nitta</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hata</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gotoh</surname> <given-names>S</given-names>
</name>
<name>
<surname>Seo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Sasaki</surname> <given-names>H</given-names>
</name>
<name>
<surname>Hashimoto</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice</article-title>. <source>J Cell Biol</source> (<year>2003</year>) <volume>161</volume>(<issue>3</issue>):<page-range>653&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1083/jcb.200302070</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Kuo</surname> <given-names>KH</given-names>
</name>
<name>
<surname>Leo</surname> <given-names>JM</given-names>
</name>
</person-group>. <article-title>Critical role of actin in modulating BBB permeability</article-title>. <source>Brain Res Brain Res Rev</source> (<year>2005</year>) <volume>50</volume>(<issue>1</issue>):<fpage>7</fpage>&#x2013;<lpage>13</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.brainresrev.2005.03.007</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Nirwane</surname> <given-names>A</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Basement membrane and blood-brain barrier</article-title>. <source>Stroke Vasc Neurol</source> (<year>2019</year>) <volume>4</volume>(<issue>2</issue>):<fpage>78</fpage>&#x2013;<lpage>82</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/svn-2018-000198</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phoenix</surname> <given-names>TN</given-names>
</name>
<name>
<surname>Temple</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Spred1, a negative regulator of ras-MAPK-ERK, is enriched in CNS germinal zones, dampens NSC proliferation, and maintains ventricular zone structure</article-title>. <source>Genes Dev</source> (<year>2010</year>) <volume>24</volume>(<issue>1</issue>):<fpage>45</fpage>&#x2013;<lpage>56</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/gad.1839510</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vriend</surname> <given-names>I</given-names>
</name>
<name>
<surname>Oegema</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Genetic causes underlying grey matter heterotopia</article-title>. <source>Eur J Paediatr Neurol</source> (<year>2021</year>) <volume>35</volume>:<fpage>82</fpage>&#x2013;<lpage>92</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejpn.2021.09.015</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carabalona</surname> <given-names>A</given-names>
</name>
<name>
<surname>Beguin</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pallesi-Pocachard</surname> <given-names>E</given-names>
</name>
<name>
<surname>Buhler</surname> <given-names>E</given-names>
</name>
<name>
<surname>Pellegrino</surname> <given-names>C</given-names>
</name>
<name>
<surname>Arnaud</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>A glial origin for periventricular nodular heterotopia caused by impaired expression of filamin-a</article-title>. <source>Hum Mol Genet</source> (<year>2012</year>) <volume>21</volume>(<issue>5</issue>):<page-range>1004&#x2013;17</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/hmg/ddr531</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watrin</surname> <given-names>F</given-names>
</name>
<name>
<surname>Manent</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Cardoso</surname> <given-names>C</given-names>
</name>
<name>
<surname>Represa</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Causes and consequences of gray matter heterotopia</article-title>. <source>CNS Neurosci Ther</source> (<year>2015</year>) <volume>21</volume>(<issue>2</issue>):<page-range>112&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cns.12322</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rami</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rabie</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Effect of thyroid deficiency on the development of glia in the hippocampal formation of the rat: An immunocytochemical study</article-title>. <source>Glia</source> (<year>1988</year>) <volume>1</volume>(<issue>5</issue>):<page-range>337&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/glia.440010506</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gould</surname> <given-names>E</given-names>
</name>
<name>
<surname>Frankfurt</surname> <given-names>M</given-names>
</name>
<name>
<surname>Westlind-Danielsson</surname> <given-names>A</given-names>
</name>
<name>
<surname>McEwen</surname> <given-names>BS</given-names>
</name>
</person-group>. <article-title>Developing forebrain astrocytes are sensitive to thyroid hormone</article-title>. <source>Glia</source> (<year>1990</year>) <volume>3</volume>(<issue>4</issue>):<page-range>283&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/glia.440030408</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berbel</surname> <given-names>P</given-names>
</name>
<name>
<surname>Guadano-Ferraz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Martinez</surname> <given-names>M</given-names>
</name>
<name>
<surname>Quiles</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Balboa</surname> <given-names>R</given-names>
</name>
<name>
<surname>Innocenti</surname> <given-names>GM</given-names>
</name>
</person-group>. <article-title>Organization of auditory callosal connections in hypothyroid adult rats</article-title>. <source>Eur J Neurosci</source> (<year>1993</year>) <volume>5</volume>(<issue>11</issue>):<page-range>1465&#x2013;78</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1460-9568.1993.tb00214.x</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berbel</surname> <given-names>P</given-names>
</name>
<name>
<surname>Auso</surname> <given-names>E</given-names>
</name>
<name>
<surname>Garcia-Velasco</surname> <given-names>JV</given-names>
</name>
<name>
<surname>Molina</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Camacho</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Role of thyroid hormones in the maturation and organisation of rat barrel cortex</article-title>. <source>Neuroscience</source> (<year>2001</year>) <volume>107</volume>(<issue>3</issue>):<page-range>383&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0306-4522(01)00368-2</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez-Galan</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Escobar del Rey</surname> <given-names>F</given-names>
</name>
<name>
<surname>Morreale de Escobar</surname> <given-names>G</given-names>
</name>
<name>
<surname>Santacana</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ruiz-Marcos</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Hypothyroidism alters the development of radial glial cells in the term fetal and postnatal neocortex of the rat</article-title>. <source>Brain Res Dev Brain Res</source> (<year>2004</year>) <volume>153</volume>(<issue>1</issue>):<page-range>109&#x2013;14</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.devbrainres.2004.08.002</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berbel</surname> <given-names>P</given-names>
</name>
<name>
<surname>Navarro</surname> <given-names>D</given-names>
</name>
<name>
<surname>Auso</surname> <given-names>E</given-names>
</name>
<name>
<surname>Varea</surname> <given-names>E</given-names>
</name>
<name>
<surname>Rodriguez</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Ballesta</surname> <given-names>JJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of late maternal thyroid hormones in cerebral cortex development: An experimental model for human prematurity</article-title>. <source>Cereb Cortex</source> (<year>2010</year>) <volume>20</volume>(<issue>6</issue>):<page-range>1462&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cercor/bhp212</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pathak</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sinha</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Mohan</surname> <given-names>V</given-names>
</name>
<name>
<surname>Mitra</surname> <given-names>K</given-names>
</name>
<name>
<surname>Godbole</surname> <given-names>MM</given-names>
</name>
</person-group>. <article-title>Maternal thyroid hormone before the onset of fetal thyroid function regulates reelin and downstream signaling cascade affecting neocortical neuronal migration</article-title>. <source>Cereb Cortex</source> (<year>2011</year>) <volume>21</volume>(<issue>1</issue>):<fpage>11</fpage>&#x2013;<lpage>21</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cercor/bhq052</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohan</surname> <given-names>V</given-names>
</name>
<name>
<surname>Sinha</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Pathak</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rastogi</surname> <given-names>L</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>P</given-names>
</name>
<name>
<surname>Pal</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Maternal thyroid hormone deficiency affects the fetal neocorticogenesis by reducing the proliferating pool, rate of neurogenesis and indirect neurogenesis</article-title>. <source>Exp Neurol</source> (<year>2012</year>) <volume>237</volume>(<issue>2</issue>):<page-range>477&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.expneurol.2012.07.019</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zamoner</surname> <given-names>A</given-names>
</name>
<name>
<surname>Funchal</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jacques-Silva</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Gottfried</surname> <given-names>C</given-names>
</name>
<name>
<surname>Barreto Silva</surname> <given-names>FR</given-names>
</name>
<name>
<surname>Pessoa-Pureur</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Thyroid hormones reorganize the cytoskeleton of glial cells through gfap phosphorylation and rhoa-dependent mechanisms</article-title>. <source>Cell Mol Neurobiol</source> (<year>2007</year>) <volume>27</volume>(<issue>7</issue>):<page-range>845&#x2013;65</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10571-006-9084-2</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veeraval</surname> <given-names>L</given-names>
</name>
<name>
<surname>O'Leary</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Cooper</surname> <given-names>HM</given-names>
</name>
</person-group>. <article-title>Adherens junctions: Guardians of cortical development</article-title>. <source>Front Cell Dev Biol</source> (<year>2020</year>) <volume>8</volume>:<elocation-id>6</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2020.00006</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thind</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Monga</surname> <given-names>I</given-names>
</name>
<name>
<surname>Thakur</surname> <given-names>PK</given-names>
</name>
<name>
<surname>Kumari</surname> <given-names>P</given-names>
</name>
<name>
<surname>Dindhoria</surname> <given-names>K</given-names>
</name>
<name>
<surname>Krzak</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Demystifying emerging bulk RNA-seq applications: The application and utility of bioinformatic methodology</article-title>. <source>Brief Bioinform</source> (<year>2021</year>) <volume>22</volume>(<issue>6</issue>). doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bib/bbab259</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lemkine</surname> <given-names>GF</given-names>
</name>
<name>
<surname>Raj</surname> <given-names>A</given-names>
</name>
<name>
<surname>Alfama</surname> <given-names>G</given-names>
</name>
<name>
<surname>Turque</surname> <given-names>N</given-names>
</name>
<name>
<surname>Hassani</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Alegria-Prevot</surname> <given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Adult neural stem cell cycling <italic>in vivo</italic> requires thyroid hormone and its alpha receptor</article-title>. <source>FASEB J</source> (<year>2005</year>) <volume>19</volume>(<issue>7</issue>):<page-range>863&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1096/fj.04-2916fje</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gothie</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Sebillot</surname> <given-names>A</given-names>
</name>
<name>
<surname>Luongo</surname> <given-names>C</given-names>
</name>
<name>
<surname>Legendre</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nguyen Van</surname> <given-names>C</given-names>
</name>
<name>
<surname>Le Blay</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Adult neural stem cell fate is determined by thyroid hormone activation of mitochondrial metabolism</article-title>. <source>Mol Metab</source> (<year>2017</year>) <volume>6</volume>(<issue>11</issue>):<page-range>1551&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molmet.2017.08.003</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodriguez</surname> <given-names>E. M.</given-names>
</name>
<name>
<surname>Guerra</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Vio</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Gonzales</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Ortloff</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Batiz</surname> <given-names>L. F.</given-names>
</name>
<etal/>
</person-group>. <article-title>A cell junction pathology of neural stem cells leads to abnormal neurogenesis and hydrocephalus</article-title>. <source>Biol Res</source> (<year>2012</year>) <volume>45</volume>(<issue>3</issue>):<page-range>231&#x2013;242</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4067/S0716-97602012000300005</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Boyer</surname> <given-names>L</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mertens</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation</article-title>. <source>Elife</source> (<year>2016</year>) <volume>5</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.13374</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morte</surname> <given-names>B</given-names>
</name>
<name>
<surname>Diez</surname> <given-names>D</given-names>
</name>
<name>
<surname>Auso</surname> <given-names>E</given-names>
</name>
<name>
<surname>Belinchon</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Gil-Ibanez</surname> <given-names>P</given-names>
</name>
<name>
<surname>Grijota-Martinez</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Thyroid hormone regulation of gene expression in the developing rat fetal cerebral cortex: prominent role of the Ca2+/calmodulin-dependent protein kinase IV pathway</article-title>. <source>Endocrinology</source> (<year>2010</year>) <volume>151</volume>(<issue>2</issue>):<page-range>810&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2009-0958</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mollgard</surname> <given-names>K</given-names>
</name>
<name>
<surname>Balslev</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lauritzen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Saunders</surname> <given-names>NR</given-names>
</name>
</person-group>. <article-title>Cell junctions and membrane specializations in the ventricular zone (germinal matrix) of the developing sheep brain: a CSF-brain barrier</article-title>. <source>J Neurocytol</source> (<year>1987</year>) <volume>16</volume>(<issue>4</issue>):<page-range>433&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/BF01668498</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whish</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dziegielewska</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Mollgard</surname> <given-names>K</given-names>
</name>
<name>
<surname>Noor</surname> <given-names>NM</given-names>
</name>
<name>
<surname>Liddelow</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Habgood</surname> <given-names>MD</given-names>
</name>
<etal/>
</person-group>. <article-title>The inner CSF-brain barrier: developmentally controlled access to the brain <italic>via</italic> intercellular junctions</article-title>. <source>Front Neurosci</source> (<year>2015</year>) <volume>9</volume>:<elocation-id>16</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnins.2015.00016</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johansson</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Dziegielewska</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Liddelow</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Saunders</surname> <given-names>NR</given-names>
</name>
</person-group>. <article-title>The blood-CSF barrier explained: when development is not immaturity</article-title>. <source>Bioessays</source> (<year>2008</year>) <volume>30</volume>(<issue>3</issue>):<page-range>237&#x2013;48</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/bies.20718</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ek</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Dziegielewska</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Habgood</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Saunders</surname> <given-names>NR</given-names>
</name>
</person-group>. <article-title>Barriers in the developing brain and neurotoxicology</article-title>. <source>Neurotoxicology</source> (<year>2012</year>) <volume>33</volume>(<issue>3</issue>):<fpage>586</fpage>&#x2013;<lpage>604</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.neuro.2011.12.009</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saunders</surname> <given-names>NR</given-names>
</name>
<name>
<surname>Dziegielewska</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Mollgard</surname> <given-names>K</given-names>
</name>
<name>
<surname>Habgood</surname> <given-names>MD</given-names>
</name>
</person-group>. <article-title>Physiology and molecular biology of barrier mechanisms in the fetal and neonatal brain</article-title>. <source>J Physiol</source> (<year>2018</year>) <volume>596</volume>(<issue>23</issue>):<page-range>5723&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1113/JP275376</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Pu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Mao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury</article-title>. <source>Nat Commun</source> (<year>2016</year>) <volume>7</volume>:<elocation-id>10523</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncomms10523</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pong</surname> <given-names>S</given-names>
</name>
<name>
<surname>Karmacharya</surname> <given-names>R</given-names>
</name>
<name>
<surname>Sofman</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bishop</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Lizano</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>The role of brain microvascular endothelial cell and blood-brain barrier dysfunction in schizophrenia</article-title>. <source>Complex Psychiatry</source> (<year>2020</year>) <volume>6</volume>(<issue>1-2</issue>):<fpage>30</fpage>&#x2013;<lpage>46</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000511552</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname> <given-names>WO</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>PK</given-names>
</name>
<name>
<surname>Silveus</surname> <given-names>E</given-names>
</name>
<name>
<surname>Dailey</surname> <given-names>ME</given-names>
</name>
</person-group>. <article-title>The protein content of the cerebrospinal fluid in myxedema</article-title>. <source>J Clin Invest</source> (<year>1928</year>) <volume>6</volume>(<issue>2</issue>):<page-range>251&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI100196</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schacht</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Tourtellotte</surname> <given-names>WW</given-names>
</name>
<name>
<surname>Frame</surname> <given-names>B</given-names>
</name>
<name>
<surname>Nickel</surname> <given-names>SN</given-names>
</name>
</person-group>. <article-title>Distribution of protein, lipid and administered bromide between serum and CSF in myxedema</article-title>. <source>Metabolism</source> (<year>1968</year>) <volume>17</volume>(<issue>9</issue>):<page-range>786&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0026-0495(68)90028-0</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nystrom</surname> <given-names>E</given-names>
</name>
<name>
<surname>Hamberger</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lindstedt</surname> <given-names>G</given-names>
</name>
<name>
<surname>Lundquist</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wikkelso</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Cerebrospinal fluid proteins in subclinical and overt hypothyroidism</article-title>. <source>Acta Neurol Scand</source> (<year>1997</year>) <volume>95</volume>(<issue>5</issue>):<page-range>311&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1600-0404.1997.tb00216.x</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frost</surname> <given-names>N</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Sweeney</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Myxedema, papilledema, and elevated CSF protein</article-title>. <source>Neurology</source> (<year>2004</year>) <volume>63</volume>(<issue>4</issue>):<page-range>754&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1212/01.wnl.0000134655.40360.ab</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pancotto</surname> <given-names>T</given-names>
</name>
<name>
<surname>Rossmeisl</surname> <given-names>JH</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Panciera</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Zimmerman</surname> <given-names>KL</given-names>
</name>
</person-group>. <article-title>Blood-brain-barrier disruption in chronic canine hypothyroidism</article-title>. <source>Vet Clin Pathol</source> (<year>2010</year>) <volume>39</volume>(<issue>4</issue>):<page-range>485&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1939-165X.2010.00253.x</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pancotto</surname> <given-names>TE</given-names>
</name>
<name>
<surname>Rossmeisl</surname> <given-names>JH</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Huckle</surname> <given-names>WR</given-names>
</name>
<name>
<surname>Inzana</surname> <given-names>KD</given-names>
</name>
<name>
<surname>Zimmerman</surname> <given-names>KL</given-names>
</name>
</person-group>. <article-title>Evaluation of endothelin-1 and MMPs-2, -9, -14 in cerebrospinal fluid as indirect indicators of blood-brain barrier dysfunction in chronic canine hypothyroidism</article-title>. <source>Res Vet Sci</source> (<year>2016</year>) <volume>105</volume>:<page-range>115&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.rvsc.2016.01.021</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ni</surname> <given-names>J</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>T</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Dang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>TSH stimulates the proliferation of vascular smooth muscle cells</article-title>. <source>Endocrine</source> (<year>2014</year>) <volume>46</volume>(<issue>3</issue>):<page-range>651&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12020-013-0135-4</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Cooper-Kuhn</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Nannmark</surname> <given-names>U</given-names>
</name>
<name>
<surname>Blomgren</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kuhn</surname> <given-names>HG</given-names>
</name>
</person-group>. <article-title>Stimulatory effects of thyroid hormone on brain angiogenesis <italic>in vivo</italic> and <italic>in vitro</italic>
</article-title>. <source>J Cereb Blood Flow Metab</source> (<year>2010</year>) <volume>30</volume>(<issue>2</issue>):<page-range>323&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/jcbfm.2009.216</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stolp</surname> <given-names>HB</given-names>
</name>
<name>
<surname>Dziegielewska</surname> <given-names>KM</given-names>
</name>
</person-group>. <article-title>Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases</article-title>. <source>Neuropathol Appl Neurobiol</source> (<year>2009</year>) <volume>35</volume>(<issue>2</issue>):<page-range>132&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2990.2008.01005.x</pub-id>
</citation>
</ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexander</surname> <given-names>EK</given-names>
</name>
<name>
<surname>Pearce</surname> <given-names>EN</given-names>
</name>
<name>
<surname>Brent</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Dosiou</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>2017 guidelines of the American thyroid association for the diagnosis and management of thyroid disease during pregnancy and the postpartum</article-title>. <source>Thyroid</source> (<year>2017</year>) <volume>27</volume>(<issue>3</issue>):<page-range>315&#x2013;89</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/thy.2016.0457</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howard</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Zhicheng</surname> <given-names>M</given-names>
</name>
<name>
<surname>Filipovic</surname> <given-names>R</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Antic</surname> <given-names>SD</given-names>
</name>
<name>
<surname>Zecevic</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Radial glia cells in the developing human brain</article-title>. <source>Neuroscientist</source> (<year>2008</year>) <volume>14</volume>(<issue>5</issue>):<page-range>459&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/1073858407313512</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edgar</surname> <given-names>R</given-names>
</name>
<name>
<surname>Domrachev</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lash</surname> <given-names>AE</given-names>
</name>
</person-group>. <article-title>Gene expression omnibus: NCBI gene expression and hybridization array data repository</article-title>. <source>Nucleic Acids Res</source> (<year>2002</year>) <volume>30</volume>(<issue>1</issue>):<page-range>207&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/30.1.207</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>